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Abstract  
 
Aims 
To successfully implement a self-medication system using blister packs. To evaluate nurse, patient 
and pharmacist opinions and perceptions.  
Methods 
A self-medication system was designed, implemented and evaluated at Graythwaite 
Rehabilitation Centre.  Patient and nurse perspectives were sought pre- and post-implementation 
using questionnaires and semi-structured interviews. The pharmacist’s perspective was captured 
via a reflective diary.   
Results 
Patients perceived that the self-medication system was convenient, time-saving and gave them a 
sense of responsibility for their health. Some expressed concern about packed medications with 
specific instructions and others found it difficult to physically remove the tablets. Nurses 
perceived that the system allowed patients to be discharged sooner, was beneficial, improved 
patient independence and saved time. They expressed concerns about patients having the 
strength to remove tablets and the possibility of patients taking medication from the wrong 
pocket. The pharmacist found the system to be a positive initiative for improving patient 
confidence and independence, however patient recruitment was challenging.  
Conclusion 
This project has achieved success in the implementation of a self-medication system. The findings 
demonstrate that the system provides many benefits to patients and nurses alike. Findings have 
added a range of unique perceptions to published literature and will enlighten others wishing to 
implement such a system. 
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1. Introduction  
 
The Society of Hospital Pharmacists of Australia (SHPA) Committee of Specialty Practice in 
Rehabilitation and Aged Care recommends that hospital rehabilitation wards allow self-
administration of medications for suitable candidates as part of the discharge planning process.(1) 
These programs enable patients to be supervised, supported and educated about their 
medications in order to promote confidence and competence in their medication 
management.(2) Problems experienced by patients (or identified by nurses) during self-
administration are recognised and steps are taken to solve them. The SHPA  recommends that 
self-administering patients be medically stable with a reasonably constant medication regime.(3) 
 
2. Aims 
 
The primary aim for this project was to implement a self-medication system using blister packs for 
selected patients in the Graythwaite Rehabilitation Centre of Ryde Hospital in Sydney.  
Another aim was to evaluate and compare nurse, patient and pharmacist opinions and 
perceptions of the system pre- and post-implementation. From this data, the success of the 
system would be evaluated and strategies to improve the system identified.   
 
3. Literature Review  
 
This chapter will explore the literature regarding the history of self-administration programs, the 
importance of such programs and gaps in knowledge. The advantages and disadvantages of using 
blister packs in self-administration programs will be discussed. Further, barriers to implementing 
such programs will be explored and the history behind the implementation of this program will be 
outlined. The scope of this literature review extends to relevant studies on an international scale. 
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3.1 History and Significance of Self-Administration  
 
The concept of self-administration of medications in hospital is not new. As early as 1959, Parnell 
et al(4)  reported a program in which patients self-administered their medications during their 
hospital stay. Since then, a variety of different programs for inpatients have been reported and 
implemented. Another researcher, Kelly(5), states that “A self-medication program increases 
patients’ independence, knowledge and compliance, and is congruent with the philosophy of 
rehabilitation.”(5, 6) Manias et al(6) found that patients who had been involved in self-medication 
systems felt increased autonomy and independence and a greater sense of control and 
confidence over their medicines.  Indeed, such a system provides an opportunity to improve 
patient education and involvement in their treatment.  
 
Self-administration is beneficial as it can potentially lead to simpler and better medication 
regimes for patients. This is due to the fact that a more comprehensive assessment of a patient’s 
medication is required before proceeding. Simplification may improve compliance, as the rate of 
non-compliance rises from 15% when patients take one medication to 35% when they are asked 
to take more than five medications.(2, 7) Improved compliance has obvious health benefits for 
the patient but also has cost benefits, particularly by preventing readmission.(2, 8) Up to one-
quarter of hospital readmissions are due to non-compliance with medication regimes.(8) 
 
Most self-administration programs reported in the literature have used outcome measures such 
as patient satisfaction, medication knowledge and medication adherence.(1, 2) There is evidence 
that these programs provide benefits such as improved medication knowledge and that patient 
satisfaction is high.(1, 2, 9-19) A review of published studies suggests that patients who have 
taken part in such programs feel they have benefited from them and are keen to participate in 
them again.(9, 11, 12, 17-21) A study by Lowe et al(10) found that of self-medicating patients, 
95% preferred self-administration, 88% felt more in control of their medicines and 43% felt more 
confident taking their medicines. Most commonly, patients found that self-administration gave 
them more control and enabled them to feel more confident about taking their medicines when 
at home.(9-19, 22) Further, a review of self-administration studies conducted by Wright et al.(9) 
found that the majority of such programs saved time for nurses by reducing the length of the 
medication administration round.(9)  Research shows that a patient’s sense of engagement and 
self-efficacy are strong predictors of outcomes.(23, 24) Quality improvement interventions need 
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to incorporate supports for patient self-management in order to positively affect patient 
outcomes.(25) The inclusion of recommendations for self-management support in a number of 
guidelines is evidence that this is a crucial component of chronic care quality.(24) 
 
Some studies did not show such positive results regarding self-administration programs. For 
example, three studies found no significant differences in adherence scores between those who 
self-administered their medication and controls.(26-28)  Newcomer(13) found no significant 
differences in missed doses between those that self-administered and those that did not, and 
Anderson(29) found there was no reduction in nursing time for medication administration. That 
being said, the vast majority of studies examined showed that self-administration resulted in 
better patient outcomes and improved patient confidence, independence, compliance, 
medication knowledge and overall satisfaction with care.(1, 2, 9-22) Studies concluded that self-
medication programs  did require a greater time investment from both nurses and pharmacists; 
however the amount of extra time varied according to patient complexity.(30-37) 
 
3.2 Gaps in Knowledge  
 
Many of the claimed advantages of self-administration programs are not substantiated by good 
scientific research. The limited number of well-designed studies, studies using questionable 
methodology, and inadequate reporting in many papers make conclusions difficult to draw.(9) 
Adding to this problem is the fact that the vast majority of published research is descriptive and 
anecdotal.(9) There are a limited number of well-designed studies with sound methodologies.(9) 
Flaws in many of the studies reviewed by Wright et al.(9) included small samples sizes or low 
response rates to questionnaires. In addition, many of those studies with low response rates 
made little or no attempt to quantify the impact that these non-responders may have had on 
their findings or conclusions.(9) As most self-administration programs were evaluated by those 
providing the service, investigator or observational bias was potentially a problem. The majority 
of studies did not attempt to minimise or correct for this bias.(9) Findings varied according to who 
was providing patient education and supporting patients in self-administration. Often it was both 
nursing and pharmacy staff that worked together to run self-medication programs; however in 
some studies self-medication and education was solely the pharmacist’s responsibility.(9, 31-37) 
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Such self-administration systems may have been implemented in the past, but not formally 
evaluated or published. Consequently, the published literature may under-represent the work 
that has been previously undertaken in hospital or rehabilitation settings.  
 
A blister pack is a dose administration aid (DAA) and is described as a non-reusable device that 
allows medicines to be housed in plastic grid-like compartments, arranged according to the dosing 
schedule.(38) Blister Packs cater for up to 4 doses per day for 7 days. Patients access the 
medications when they are due to be taken by popping the tablets out through a foil backing. 
Blister packs may be an underutilised tool in hospital self-administration systems. No published 
reports of an inpatient self-administration program using blister packs were identified. Blister 
packing medications comes with its own unique set of challenges; these include: stability of 
medications when exposed to light and changes in humidity, dealing with medication changes in 
hospital, accommodating Schedule 8 and Schedule S4D medications (i.e. Controlled Drugs with 
strict storage and accountability requirements) whilst complying to legal  requirements in 
hospital, accommodating medications to be taken on an empty stomach or away from other 
medicines such as thyroxine and bisphosphonates, and managing  ‘as required’ medications.(3, 
39-43)  Another consideration is that local guidelines and procedures need to comply with 
legislative requirements as well as policy directives such as the Medication Handling in NSW 
Health Care Facilities (2013) developed by the NSW State Government.(3, 41, 43, 44) 
 
 
Consequently, the area of self-medication programs, although studied widely over many years, 
still poses unanswered questions and further research needs to be conducted. This is particularly 
true for the use of blister packing as a medication delivery system in such programs. Since this 
method of medication delivery in self-administration programs had never previously been 
reported in published studies, it was considered important to implement and evaluate such a 
system, and explore both nurse and patient opinions and perceptions both pre- and post-
implementation.  A pharmacist’s perspective would also be valuable in the evaluation of this 
system, and would provide another dimension which may not be addressed in published studies. 
The pharmacist would document any issues regarding patient recruitment, and perceived benefits 
and challenges faced in the system’s implementation and operation. This would be adding 
information to the body of self-administration studies available in the literature. Outcomes from 
this study would then be compared to findings in published studies to elicit differences in patient 
and staff attitudes and perceived benefits and challenges of a blister pack system as opposed to 
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conventional self-administration delivery systems in a rehabilitation inpatient setting. The findings 
would also provide valuable information about the benefits, barriers and enablers of 
implementing such a system for other rehabilitation units who are considering implementing a 
self-administration system using blister packs in the future. 
 
3.3 Blister Packs as a Dose Administration Aid 
 
Compliance aids, such as blister packs, have been shown to facilitate adherence.(45-47) Blister 
packs as a form of dose administration aid have unique advantages and disadvantages in their use 
and effectiveness. They can greatly benefit patients who have cognitive impairment, especially 
those that cannot recall if they have taken their medication for the day.(47, 48) Confusion could 
potentially lead to tablets being omitted or doses being duplicated. If this occurs with medications 
with a narrow therapeutic index, results could potentially be dangerous for the patient. Cognitive 
impairment may also result in patients not understanding how to take their medication properly 
and at what time of day they should be taken.(47, 48) Blister packs can resolve both these issues, 
as tablets are packed to be taken at particular times of day in a weekly pack. This eliminates the 
need for patients to work out when and how often their tablets are to be taken. Further, patients 
and carers can visually see when medications have been taken or doses forgotten.  Blister packs 
also eliminate the need for patients or carers to store and manage prescriptions and repeats, as 
the community pharmacy can keep track of prescriptions and remind patients to see their doctor 
when repeats run out. For patients who live alone, blister packs have been shown to promote 
independence and improve confidence.(48) For patients with a carer, blister packs can make the 
process of giving medication easier and allow the carer to inspect whether doses have been 
missed.(46, 47) 
 
Along with the advantages of blister packs there are also some disadvantages of using this dose 
administration system. One is that patients with physical disabilities such as arthritis may 
experience difficulty removing their medication from the foil pockets of the blister pack(46-48); 
however pill punchers are available to help patients extract their medication if needed. A pill 
puncher or Pil-Bob® is a device that uses a plastic spike to puncture the blister pack pocket and 
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catch the tablets that drop from the blister in an attached cup. This facilitates the process of 
accessing medications for those patients which find it difficult due to poor strength, dexterity or 
eyesight.  Blister packs are not child-proof and hence must be kept in a safe area out of reach of 
children.(47, 49) They do not provide enough room for ancillary or advisory labels to be attached, 
thereby patients often miss out on valuable warnings and advice. Patients with poor vision may 
not notice medications inadvertently left behind in a blister pack, especially if they are a clear 
liquid capsule such as Vitamin D or Fish Oil capsules. -  Blister packs are generally only appropriate 
for regular medication, hence any ‘as required’ medication cannot be packed in such a device.(48) 
Non-oral medications (e.g. eye drops, inhalers, patches, creams, nasal sprays, etc.) are not 
suitable for blister packing. Stability of oral tablets can also be a problem when extracted from 
their original packaging, and stability data is usually not available from drug companies for 
medications removed from their original packaging. Further, the following solid oral dosage forms 
should not be packed in a blister pack(48, 50):  
- Effervescent tablets e.g. effervescent forms of ranitidine, cimetidine, potassium 
chloride, soluble aspirin tablets 
- Dispersible tablets 
- Buccal tablets 
- Chewable tablets e.g. ascorbic acid  
- Sublingual tablets e.g. glyceryl trinitrate sublingual tablets 
- Significantly hygroscopic preparations e.g. sodium valproate 
- Solid dose cytotoxic preparations e.g. methotrexate 
- Tablets exceedingly susceptible to light degradation e.g. nifedipine, tamoxifen 
- Moisture-sensitive medicines such as wafers e.g. olanzapine wafer, ondansetron 
wafer 
 
3.4 Barriers to the Implementation of a Self-Administration System 
 
Historically, concerns about patient safety have proven to be the largest barrier to the 
implementation of self-administration programs.(51) Safety issues include concerns about the 
possibility of patients taking the wrong medication, the wrong dose or taking their medicines at 
the wrong time, amongst others. Another common concern is that of who would be accountable 
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if a patient suffered harm or an adverse outcome. As self-administration programs often require 
additional resources for establishment and maintenance, this is also seen as a barrier to 
implementation.(51) 
It is important to quantify the time commitment required to set up a self-administration program. 
However, it is both challenging and complicated to measure staff time required to set up such a 
system with any precision (9), since staff members are continuously being interrupted due to the 
nature of their professions in acute care.  Another point to consider is that time taken in 
implementing and maintaining such a program will be heavily dependent on the program design 
and complexity. Hence, it is  very difficult to estimate average time and staff resources required 
for self-administration, as resources discussed in the literature are dependent on the type  of  
self-administration program, along with the nature of the centre in which it is implemented.(9)  
 
3.5 Genesis of Medication Self-Administration in the Graythwaite 
Rehabilitation Centre 
 
Ryde Hospital is part of the Northern Sydney Local Health District, and, along with Royal North 
Shore Hospital, forms the North Shore Ryde Health Service in New South Wales. Ryde Hospital has 
134 acute beds and 64 sub-acute rehabilitation beds. The rehabilitation centre specialises in 
caring for orthopedic, severe burns, and neurology patients.  The role of the rehabilitation 
pharmacist is to deliver a clinical service to the two rehabilitation wards. This includes but is not 
limited to: providing pharmaceutical care to all patients, giving clinical advice to prescribers and 
nursing staff, provision of education via in-services to nursing staff, providing drug administration 
advice to doctors and nurses, completing thorough medication reconciliation on admission and 
discharge, screening discharge prescriptions, counseling patients on medications, giving lifestyle 
advice to patients as appropriate, reviewing prescribed medication  regimens regularly, and 
working as part of a multidisciplinary team. The two wards comprising the Graythwaite 
Rehabilitation Centre at Ryde Hospital each contain 32 inpatient beds, with a pharmacist to 
patient ratio of 1:64. 
The idea of setting up a self-medication system for appropriate rehabilitation patients was 
conceived by the Rehabilitation Working Party prior to the construction of the Graythwaite 
8 
 
Rehabilitation Centre in 2013. The rehabilitation process involves facilitating the recovery process 
for patients post injury, illness or disease. This also encompasses the need to ensure patients are 
capable of managing their medications at home. From this ideal, the establishment of a self-
medication system was suggested by a team of medical consultants when planning commenced 
for the construction of the rehabilitation facility.   
 
Since rehabilitation patients often have a length of stay of over two weeks, and may or may not 
have functional deficits as a result of their condition, it was decided that these patients would 
benefit from self-administration more than regular acute hospital inpatients. Some examples of 
patients that would benefit from the use of blister packs may include patients recovering from 
stroke or patients with Parkinson’s disease, who may be unable to open bottles and boxes due to 
limb weakness or dexterity issues. These patients may benefit from the blister pack system of 
administration and could use devices to help them open the blisters if required. Patients who 
require many new medications as a result of their condition or surgery (e.g. post stroke, post total 
knee replacement) may also benefit from learning about their new medicines in hospital and self-
administering under nurse supervision. This allows patients to become confident in managing 
their medications and improves independence on discharge.  
 
The evaluation of this self-administration system will address opinions, beliefs and concerns 
regarding its implementation (pre-implementation) and compare these to experiences and 
opinions once the system has been successfully implemented (post-implementation).  The 
evaluation will focus on the perceived benefits of the system in terms of increasing patient 
autonomy, confidence and ability to manage their medicines independently at discharge. It is 
anticipated that this system will enhance medication compliance, reduce confusion and improve 
patient confidence. It is predicted that there will be some initial resistance to change and concern 
regarding medication verification from nurses; however, it is believed that once the system has 
become familiar these concerns will dissipate and the system will be seen as a positive and 
beneficial intervention.  
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4. Methods 
 
The study was undertaken at the Graythwaite Rehabilitation Centre at Ryde Hospital in Sydney, 
Australia. The implementation of the self-medication system was undertaken by myself, the ward 
pharmacist, and facilitated by the nursing staff. The pharmacist overseeing this study was the 
principal investigator. Hence, when ‘the pharmacist’ is referred to in this document, it is also a 
reference to the principle investigator, unless otherwise specified.   
 
4.1 Participant Recruitment 
4.1.1 Nurse recruitment 
 
All nurses working in the Graythwaite Rehabilitation Centre during the study period were eligible 
to participate in the study. Nurses were introduced to the project via multiple pharmacist-led in-
services on the rehabilitation wards. Approximately 85% of nurses attended one of these four 
sessions. The education covered the following aspects:- 
- Patient’s role  
- Nurse’s role  
- Pharmacist’s role  
- Benefits of self-medication  
- How patients were to be selected (i.e. inclusion and exclusion criteria) 
- How data would be collected 
- How data would be analysed 
- How nurses would verify what medications are packed and check against the medication 
chart 
- Medications that wouldn’t be packed e.g. Schedule 8 drugs 
- How to manage dose changes, doses withheld and refused medications 
- How to identify which patients are enrolled in the study 
- Storage of blister packs 
- Supply of blister packs 
- Discharge planning  
10 
 
 
After each education session, nurses who agreed to participate in the study were asked to read 
the Nurse Participant Information Sheet and sign the Consent Form (Appendix 1).  
4.1.2 Patient Recruitment  
 
Selection for inclusion in the study was based on the following inclusion and exclusion criteria: 
 
Inclusion criteria(3, 40): 
- Intending to self-administer medications post-discharge 
- Prescribed five or more regular medications at the time of enrolment  
- Medically stable 
- Prescribed a relatively stable medication regimen (preferably unchanged over  the last 
seven days) 
- Willing to provide written informed consent 
- Identified by the NUM, pharmacist, nursing staff, medical staff or allied health as highly 
likely to benefit from using a blister pack  
- Willing to consider continuation of blister pack use after  discharge  
- Willing to pay for the blister packing service from their nominated pharmacy if they wish 
to continue with blister packs after  discharge  
 
Exclusion criteria(3, 40):  
- Patients discharged to a nursing home  
- Patients discharged to a residential care facility in which medications are not self-
managed 
- Patients already using a blister pack on admission  
- Patients with a history of dementia or moderate to severe cognitive impairment (defined 
as MMSE ≤ 20) 
- Poor English communication skills  
- Unwilling or unable to provide written consent 
 
Patient participants were selected in a variety of ways; some patients were nominated as 
potential study candidates in the weekly case conference meeting by members of the 
11 
 
multidisciplinary healthcare team after group discussion, while others were nominated to the 
principal investigator directly from members of the multidisciplinary team (most commonly social 
workers and occupational therapists). Some patients were nominated by the Nursing Unit 
Managers (NUMs), and the principal investigator approached others if they had been assessed as 
appropriate candidates from review of their inpatient files and background.  The principal 
investigator discussed the option of being involved in the self-medication study with patients if 
they met the inclusion criteria. Patients were given a copy of the Patient Information Sheet and 
Consent Form (See Appendix 1) to read and sign if they agreed to participate. Approximately 60% 
of suitable patients approached agreed to participate in the study. 
 
Patient participants in the trial were identifiable by a few means. Firstly, trial patients were 
flagged on the nursing handover. Secondly, trial patients could be identified by a bright pink 
sticker attached to the front of each medication chart which read “WEBSTER PACK”. This sticker 
identified   patients as belonging to this project. Further, for each study participant, packed 
medications were labeled on the medication chart by the principal investigator. Each packed 
medication had the words “In blister pack” written next to the order to alert nurses that this 
particular medication was included in the patient’s current blister pack.     
 
Each participant was de-identified and allocated a unique identifier code e.g. P:1 for patient one, 
N:5 for nurse five. De-identification occurred upon enrolment of each participant. Each piece of 
data collected from patient and nurse participants thereafter were de-identified in this same way.  
The document that recorded participant names and corresponding codes was stored on a 
password-protected computer in the Pharmacy Department. These codes were used to match 
data obtained from each participant. This meant that questionnaire and interview responses 
could be matched and compared for each participant (i.e. P:1 for questionnaire data was the 
same patient allocated code P:1 for interview data).  
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4.2 Data Collection  
4.2.1 Nurse Perspective  
 
Following the pharmacist-led education sessions, nurses who agreed to participate in the study 
were asked to complete the nurse pre-implementation questionnaire (Appendix 2). The 
questionnaire was designed to obtain initial nurse opinions, thoughts and attitudes towards the 
system before implementation. Questions related to their beliefs, attitudes and concerns towards 
the implementation of this service. The majority of questions in the questionnaires were closed-
ended and required the use of tick boxes or Likert scales to maximise response rate(1) and allow 
for reporting using descriptive statistics and quantitative statistical analysis. Questionnaire 
responses utilised Likert-scale type gradation (5 points) to indicate the level of agreement with 
each statement posed (1=Strongly Disagree to 5=Strongly Agree, with a neutral value in the 
middle). Open-ended questions were also asked to elicit what nurses believed would be the 
benefits of the system and also what their concerns were. A total of 27 nurses (68%) completed 
the pre-implementation questionnaire. 
Five nurses were randomly selected and approached individually to participate in a semi-
structured interview (Appendix 3). The purpose of the interview was to delve deeper into nurse 
opinions, beliefs and concerns about the self-medication system pre-implementation. This 
allowed the selected nurses to more thoroughly communicate their thoughts, reservations and 
uncertainties. It also allowed the nurses to express their support for the trial and their 
perceptions of how this system will benefit patients. The interviews were audio-recorded.  
 
Three months after the implementation of the self-administration system, nurses were asked to 
complete the post-implementation questionnaire (Appendix 4). Questions asked were very similar 
to the pre-implementation questionnaire; this was performed in order to compare and contrast 
initial nurse opinions, thoughts and concerns with those after having experienced the system in 
practice. These were collated and summarised to be used in the analysis of nurse perspectives. A 
total of 32 nurses (80%) completed the post-implementation questionnaire. 
Five nurses were interviewed face-to-face post-implementation in order to get a better 
understanding of their experiences with the system, their opinions and any issues they 
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encountered. They were asked about how the system benefited patients, problems experienced 
and if they had suggestions for improvement. These interviews were also semi-structured, face-
to-face and audio-recorded. Nurse interviews continued until no new information emerged. They 
ranged from 2-10 minutes in length. 
4.2.2 Patient Perspective 
 
Patients that met the inclusion criteria were educated about the system and agreeable patients 
were asked to read the Patient Information Sheet and sign the Consent Form (Appendix 1).(3, 40) 
Any questions about the study were answered.(3) Participants were asked to complete a patient 
pre-implementation questionnaire (Appendix 5) upon enrolment before blister packs were 
arranged. Similar to the nurse questionnaire, this patient questionnaire collected basic 
demographic information and used Likert scales to collect initial patient thoughts, opinions and 
concerns regarding the potential benefits and issues arising from self-medication in hospital. A 
total of twenty-three patients agreed to participate in the study. 
Upon discharge home from the rehabilitation unit, study participants were asked to complete a 
post-implementation questionnaire (Appendix 6). The post-implementation questionnaire asked 
very similar questions to the pre-implementation questionnaire, the idea being that answers 
could be compared to measure changes in opinions, attitudes and thoughts about medication 
self-administration. Similarly to the nurse questionnaires, the majority of questions were closed-
ended and required the use of tick boxes or Likert scales. Patients were also encouraged to 
respond to open-ended questions to be used in the analysis of patient perspectives. 
Twenty patient participants were interviewed by the principal investigator prior to discharge 
using a semi-structured interview technique. During the interviews, which were audio-recorded, 
patients were prompted to talk about their individual experiences with self-administration. The 
interviewer asked patients whether they felt they had benefited from the self-administration 
system and how, what suggestions they had for improvement, and if they had experienced any 
problems or concerns using the blister packs. Interviews ranged from 2-8 minutes in length.   
Furthermore, demographic data was collected for each patient participant. This data included:  
- Age 
- Sex 
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- Education 
- Living arrangement 
- Medical history 
- Medication history 
- Number of days in the study 
- Length of stay in the rehabilitation ward 
- Length of overall hospital stay 
4.2.3 Pharmacist Perspective 
 
The pharmacist’s perspective was collected via the use of a reflective diary over the course of 
implementing and evaluating the self-medication system. The diary documented a range of 
experiences, including   patient recruitment challenges, issues, and blister packing errors (and 
their resolutions). Nursing queries raised in the multiple education sessions were also recorded, 
along with their corresponding solutions.   
The reflective diary also recorded challenges encountered during the project such as time 
management issues and patient resistance to change.  Reasons for refusal of participation were 
recorded for many appropriate patient candidates who declined to participate in the study (See 
Appendix 9).  
During this study the principal investigator took a period of annual leave. The study was handed 
over to another clinical pharmacist to continue patient recruitment and data collection. This 
ensured that recruitment numbers were maximised and ensured that blister pack supply was 
continued for enrolled patients over that period.  
4.3 Data Analysis 
 
Evaluation of this self-medication initiative was performed using a ‘mixed methods’ approach (i.e. 
qualitative and quantitative data collection and analysis), which utilised a variety of sources 
including paper questionnaires and semi-structured interviews with nurses and patients. The 
pharmacist’s reflective journal of the design, implementation and evaluation of the system was 
also used as a source of data.  
15 
 
Qualitative data collected from patient and nurse interviews and the principal investigator’s 
reflective diary were thematically analysed to ascertain the most common themes expressed. 
Qualitative results were compared and combined with the quantitative results to obtain a well-
rounded and balanced view of the self-administration system, its benefits, its downfalls and its 
potential for improvement.  
4.3.1 Quantitative Data 
 
Quantitative analysis was performed on matched patient pre- and post-implementation 
questionnaires using the McNemar-Bowker test of symmetry and Stuart–Maxwell test for 
marginal homogeneity.(47)  These tests identified trends between pre- and post-implementation 
responses whilst testing for statistically significant changes. Nurse questionnaire data could not 
be matched as the same nurses did not complete the pre- and post- questionnaires. Nurse data 
were analysed using two-sample Z tests and differences in sample proportions pre- and post-
implementation were detected (see section 4.3.3 Statistical Analysis for further details of 
statistical methods used in data analysis). These results were used to make inferences about the 
success of the system and how it could be improved. 
4.3.2 Qualitative Data 
 
Patient and nurse interviews were thematically analysed by the principal investigator using an 
inductive approach. Each interview was listened to multiple times and themes recorded along 
with quotes to support these. Time restrictions did not allow for verbatim transcription of the 
interviews. The validity of the thematic analysis using this method was assured by having a 
selection of interview audio recordings (27% of total) independently evaluated by the University 
supervisor and pharmacy intern. These analyses were compared to those of the principal 
investigator and any discrepancies noted, as a strategy to minimise investigator bias. A selection 
of eight interviews (from a total of thirty) were independently evaluated in this way. The 
comparison of these analyses saw themes and findings to be essentially identical. Therefore, it 
was concluded that interview findings were valid and bias was unlikely. 
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Common themes were found to emerge in both the nurse and patient interviews and trends in 
responses were noted. Nurse pre-implementation interviews were compared to nurse post-
implementation interviews in order to assess if initial concerns became a reality and whether 
their experiences of the system were overall positive. This also allowed for the comparison 
between nurse expectations and actual experiences of the system.  
Entries in the pharmacist’s reflective diary were collated and thematically analysed also. Common 
themes were repeated throughout the diary at various time points during the study. Benefits and 
issues regarding the self-administration system were grouped and thematically analysed by the 
principal investigator.  
Data collection was restricted to a certain time period in order to meet the deadline set for 
submitting this final thesis. Patients were recruited and data collected from mid-April to mid-
August 2015. 
 
4.3.3 Statistical Analysis  
 
The statistical analysis software known as ‘Stata version 13’ (Statacorp, College Station, Texas) 
was used for all quantitative analyses. The data was checked for missing, invalid and outlying 
values and revised accordingly. Patient and nurse data was collected at two time points, pre- and 
post-implementation, and the responses from these two points in time were compared. 
Questionnaire responses utilised Likert-scale type gradation  (5 points) to indicate the level of 
agreement with each statement (1=Strongly Disagree to 5=Strongly Agree, with a neutral value in 
the middle ).A decision was made to treat Likert scale item responses as ordered categories (i.e. 
categorical data) and present data as counts and percentages. The Likert scale categories were 
compressed into 2-3 groups for the comparative analysis. 
 
It was decided that a shift in response categories from the pre- to post- time points would also 
indicate a change in patient and nurse experiences and opinions of the self-medication system 
over time. To descriptively measure these shifts, the proportions of responses on each item were 
compared pre- and post-implementation. A significant shift in the level of agreement within each 
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statement over time would provide valuable empirical evidence of effective implementation as 
well as highlight areas requiring improvement.  
 
Appropriate statistical methods were used to test for significance of shifts over time. Patients 
completed pre- and post-implementation questionnaires. Matched results were analysed using 
the McNemar-Bowker test of symmetry and Stuart–Maxwell test for marginal homogeneity.(53)  
These tests were selected for the statistical analysis as they assess the level of agreement (and 
shift) between two measurements for paired data. The McNemar-Bowker test of symmetry and 
Stuart–Maxwell test for marginal homogeneity are appropriate for paired (dependent) categorical 
data, such as that collected in the patient questionnaires. Other statistical tests, such as the chi-
squared test, do not account for such dependencies and were not appropriate for a paired analysis. 
An alpha level of p<0.05 was considered statistically significant.  
 
Due to the relatively small sample size in the patient cohort, variables were dichotomized, by 
combining the categories [Agree/Strongly Agree] and [Neutral/Disagree/Strongly Disagree] for the 
perceived benefits, and categories [Disagree/Strongly Disagree] and [Neutral/Agree/Strongly 
Agree] for the perceived concerns.  This approach increased numbers in each category and 
improved statistical power.  Dichotomised variables were analysed using McNemar’s Test for 
correlated proportions. 
 
Due to the fact that identical nursing staff did not provide responses to the pre- and post-
implementation questionnaires, it was not possible to assess change over time from the same 
cohort of nurses. This limitation meant pre- and post-implementation data were analysed as 
independent samples. A two-sample Z test compared and tested for any significant differences in 
sample proportions pre- and post-implementation. Since we were most interested in changes 
towards ‘Agreement’ for questions relating to the benefits of the system, and conversely in 
changes towards ‘Disagreement’ for questions relating to concerns, these were the categories of 
comparisons for relevant Z-tests. Again, p<0.05 was considered a statistically significant finding. 
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4.4 Intervention Protocol 
 
The blister pack used in this study was the PractiCare® brand.   It contained pockets for Morning, 
Noon, Dinner and Bedtime medications (See Figure 1). The reverse side of the pack contained an 
attached list, created by the principal investigator for each patient, which specified which 
medications were packed in each blister pocket including details of the drug name, brand name, 
strength, form and a visual description of the tablet or capsule. Further, each medication had its 
indication for use specified on this list e.g. ‘Controls blood pressure’. Each blister pack was labeled 
with the patient’s full name and ward. Advisory labels were not attached to the blister packs.  
 
Figure 1: PractiCare blister pack system(52) 
 
The principal investigator designed and managed the self-administration system; this involved 
ordering packing materials, educating the nurses, ordering blister packs from the pharmacy 
department on a weekly basis, modifying packs as required and collecting data from patients and 
nurses for evaluation purposes. Data was collected pre-implementation, post-implementation 
and as required during the study upon patient enrollment and discharge. The nurses were 
involved in supervising patients who were self-administering and reporting any issues or problems 
to the principal investigator when they arose.  Nurses were responsible for ensuring packs were 
stored in the patient’s locked bedside drawer as per hospital protocol; they were to unlock the 
drawer and supervise patient self-administration when doses were due. Nurses were also 
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expected to encourage enrolled patients to self-administer non-packed medications under 
supervision e.g. eye drops, inhalers, patches, etc.  
The study took place between March and August 2015. Data collection ceased in mid-August in 
order to allow sufficient time for Thesis completion by late September 2015. The self-medication 
system was established with the full support of all clinical and managerial staff in the Graythwaite 
Rehabilitation Centre. Setting up the system required careful consideration of how it was going to 
operate in the current inpatient rehabilitation setting.  
Under the guidance of the pharmacy manager and medical supervisor, procedures and processes 
required to implement and evaluate such a system were established. Background research 
identified only one rehabilitation centre in Sydney which used blister packs for self-
administration. The pharmacy department of this centre was contacted, their procedures 
discussed and self-medication protocols examined. It was found that their protocol was not easily 
transferable to the study setting as it was very specific to their particular work processes; 
however, the skeleton model was used as inspiration for the self-medication system implemented 
at Graythwaite Rehabilitation Centre. From there a research protocol was written, followed by 
interview questions and the design of surveys. The research protocol was forwarded to the Nurse 
Unit Managers (NUMs) of the wards and the Rehabilitation Department Head for approval. 
Educational presentations were written and delivered to educate nursing staff in the Graythwaite 
Rehabilitation Centre about the system and how it would affect their work and responsibilities. 
Education sessions were not compulsory, however nurses were highly encouraged to attend.  
From there, questionnaires and interviews that would be used to evaluate the system were 
designed. Questions were designed to capture patient and nurse opinions and concerns and were 
inspired by end-points collected in similar studies in the literature (i.e. measures of confidence, 
independence, satisfaction, adherence, etc).(9) Once this was completed, patient recruitment 
commenced.  
In summary, the establishment of the new self-administration system required nurse education, 
multidisciplinary involvement in recruitment of patients, and teamwork between nursing and 
pharmacy staff to ensure smooth operation.  
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4.4.1 Supply of Blister Packs 
 
Blister packs were ordered from the Ryde Hospital Pharmacy via a faxed order sent by the 
principle investigator. Appropriate times for drug administration(3) were considered and 
scheduled administration times altered as appropriate on the National Inpatient Medication Chart 
(NIMC) to complement the blister pack scheme. Blister packs allowed for four administration 
times per day.  
Blister packs were assembled in the Pharmacy Department by a pharmacy assistant.  A final check 
of the contents of each blister pack was performed by the pharmacist on duty in the dispensary 
and cross-checked with the current medication chart before packs were sealed. Established study 
participants had their blister packs assembled each Thursday for the following week as this fit in 
best with the pharmacy’s workflow and workload. Newly enrolled patients required a blister pack 
to be packed and delivered as soon as possible on the day of enrolment.  
4.4.2 Medication Changes  
 
Medication changes for enrolled blister pack patients required nurses and/or prescribers to 
contact the principal investigator/pharmacist as soon as possible in order to modify the blister 
pack. Examples of possible medication changes include change of drug, change of dose or 
cessation of a drug. The change was then confirmed with the medication chart and patient notes. 
The blister pack and the patient’s current medication chart were  then brought down to Pharmacy 
to be altered by the pharmacy technician, checked and verified by the pharmacist on duty and 
delivered to the ward in time for the next dose. Blister packs were altered and a new foil backing 
attached in the case of minor changes to medications. Multiple medication changes required the 
blister pack to be repacked completely.   
Nurses were required to sign the medication chart for each medication given, including those in 
the blister packs. Nurses were responsible for checking which medications were packed and 
signing for these when they witnessed the patients swallowing the tablets. The packed 
medications could be identified by a medication list on the back of each blister pack. Nurses 
signed with an ‘S’ for self-administration on the chart if the medication was blister packed.  
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4.4.3 Identifying Inappropriate Medications for Blister Packing 
 
Certain medications required special consideration when identifying whether they would be 
suitable for inclusion in a blister pack.(3) The SHPA Guidelines on Medication Self-Administration 
deems the following medications as inappropriate for storage in blister packs (Table 1):  
Table 1: Medications deemed inappropriate for blister packing and reasons 
Medication inappropriate for blister packing Reason 
Schedule 8 drugs Must be stored in a locked safe as 
per NSW Health Policy directive.(3, 
40, 41, 43) 
 
Schedule 4D drugs Must be stored in a locked safe as 
per NSW Health Policy directive.(3, 
40, 41, 43) 
 
Variable dose drugs (e.g. warfarin, reducing doses of 
prednisone, etc.) 
Doses change too frequently to 
warrant packing in a seven day 
blister pack. 
 
As needed (PRN) Medication Doses not required regularly. 
Dependent on patients’ needs.(41) 
 
STAT medication Once-off medication not 
appropriate for blister packing. 
 
Short course medication e.g. antibiotics Short term medication. Could 
cause nurse and patient confusion 
if packed.(41) 
 
Non-oral medication (e.g. inhalers, eye drops, 
suppositories, creams, ointments, injections, patches) or 
not swallowed whole (e.g. sublingual tablets, chewable 
tablets, wafers, etc.) 
 
Not appropriate for inclusion in a 
blister pack as not in oral form or 
not swallowed whole.(39, 41) 
Items requiring refrigeration  
  
 
 
Requires storage conditions 
between 2-8°C. Pack to remain at 
room temperature and to be 
stored in patient bedside 
drawer.(3, 40, 41) 
 
Medications deemed to be unstable out of their original 
packaging (e.g. sodium valproate, dabigatran, effervescent 
tablets) 
 
These medications are unsuitable 
for removal from their original 
packaging due to stability 
concerns.(39, 41, 42) 
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Cytotoxic medication e.g. methotrexate Poses a risk to nursing staff who 
may come in contact with a 
cytotoxic medication in a blister 
pack that may be inadequately 
marked as such.(41) 
 
  
5. Ethical Considerations  
 
 
Ethics approval was obtained to implement and formally evaluate this initiative from both the 
Northern Sydney Local Health District (NSLHD) Research Office and the University of Queensland 
(UQ) Ethics Committee. UQ ethics approval was sought as the work would be submitted to the 
University as a research project towards a Master of Clinical Pharmacy and potentially published 
in a peer-reviewed journal in the future.   
Ethical clearance was granted by the Northern Sydney Local Health District Research Office on 
20th February 2015 (Appendix 7). The project was deemed to be a Low or Negligible Risk research 
project (HREC reference number: LNR/15/HAWKE/28, NSLHD reference number: RESP/15/17). 
This study adheres to the Guidelines of the Ethical Review Process of The University of 
Queensland and the National Statement on Ethical Conduct in Human Research. As such it was 
granted ethics approval for a Low or Negligible Risk research project on 4th March 2015 (Approval 
Number 2015000278) (Appendix 7). 
 
Written informed consent was obtained from each participant at the time of recruitment in the 
form of a signed agreement to participate. These documents were filed in a locked cabinet in the 
Pharmacy Department. The consent form was preceded by participant information about the 
study. This information addressed: 
- The aim, objectives and details of the project 
- The potential benefits of the research  
- The data collection techniques  
- The demands on participants (e.g. time, duration of project) 
- What data was being collected 
- The confidentiality with which data will be stored 
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- That participation in the research project is entirely voluntary and participants may 
withdraw at any time without prejudice 
-      The name and contact details of the appropriate person to answer any further questions  
 
Patient and nurse confidentiality was maintained throughout the study. As mentioned previously, 
each patient and nurse participant was de-identified and assigned a unique identifier code.  The 
document that recorded participant names and codes was stored on a password-protected 
computer in the Pharmacy Department. All information provided during interviews or in 
questionnaires was treated as confidential. Data collected was stored either in hard copy in a 
locked cabinet or electronically on a password protected desktop computer in the Pharmacy 
Department.  
 
 
6. Results   
 
 
Baseline characteristics of the 23 enrolled patients are displayed in Table 2. Patient ages ranged 
from 60-91 years and the majority (16/23; 70%) of participants were female. The highest level of 
education was most frequently secondary school and most patients (87%) lived at home, either 
alone or with family. The number of days in the study varied widely from 2-77 days, the mean 
being 16 days. Similarly, the length of stay in the rehabilitation ward and overall hospital stay also 
varied significantly between patients. The mean length of stay in the rehabilitation ward was 27 
days and mean length of admission was 46 days.  
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Table 2: Baseline characteristics of enrolled patients 
Patient 
No. 
Age 
(years) 
Sex 
(M/F) 
Highest Level 
of Education 
Living 
Arrangement 
Number of 
days in the 
study 
Length of stay 
in the 
rehabilitation 
ward (days) 
Length of overall 
hospital stay 
(days) 
1 68 F Postgraduate 
degree 
Home alone 11 32 38 
2  73 M Secondary 
school 
Home alone  
 
12 26 48 
3 88 M Secondary 
school 
Home alone  
 
27 30 34 
4 72 F Secondary 
school 
Home with 
family  
 
25 39 58 
5 91 M Undergraduate 
degree 
Home with 
wife 
13 29 38 
6 70 M Secondary 
school 
Home alone  
 
12 18 29 
7 74 F Secondary 
school 
Home with 
husband 
12 14 25 
8 68 F Primary school Home alone  20 78 78 
9 76 F Postgraduate 
degree 
Retirement 
village 
8 18 81 
10 79 M Primary school Home alone  2 20 28 
11 84 M Secondary 
school 
Home with 
wife 
17 20 35 
12 78 F Undergraduate 
degree 
Home alone 16 25 34 
13 80 F Secondary 
school 
Retirement 
village 
7 14 21 
14 60 F Secondary 
school 
Home alone 9 21 56 
15 84 F Secondary 
school 
Home with 
son 
13 16 56 
16 91 F Secondary 
school 
Home with 
family 
14 15 32 
17 78 F Secondary 
school 
Retirement 
village 
12 36 36 
18 81 F Secondary 
school 
Home alone 15 18 34 
19 89 F Primary school Home alone  5 5 38 
20 85 F Secondary 
school 
Home with 
family  
77 105 137 
21 71 F Undergraduate 
degree 
Home alone 8 9 19 
22 69 M Undergraduate 
degree 
Home with 
family  
15 25 74 
23 70 F Secondary 
school 
Home alone 13 15 22 
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6.1 Patient Perceptions 
 
Overall, the results from combined quantitative and qualitative data found that patients 
perceived that the self-medication system was convenient, saved time for the nurses, gave them 
a sense of responsibility for their health care and improved their relationships with their doctors 
and nurses. Some patients felt concerned about packed medications that were required to be 
taken with specific instructions (e.g. empty stomach), and others expressed that they found it 
difficult to physically remove the tablets from the blister pack. For some aspects, perceptions 
changed before and after experiencing the self-medication system, some of which were 
statistically significant. These included perceptions of whether the system allowed patients to be 
discharged sooner, along with patient concerns regarding medication accuracy.  Other aspects of 
the quantitative data exhibited trends but did not reach statistical significance.    
 
6.1.1 Perceived Benefits – Patient Questionnaires (Quantitative Data 
Analysis) 
 
Results of quantitative data analysis displayed in Tables 3 and 4 show the thoughts and 
perceptions of patients both pre- and post-implementation with regards to the benefits that the 
system had delivered. This data was collected via the pre- and post-implementation patient 
questionnaires. Open-ended questions were included in the questionnaire and responses 
analysed. Table 4 shows p-values obtained using the McNemar’s Test for correlated proportions. 
Variables were dichotomised (i.e. columns combined) to increase the probability of obtaining 
statistically significant results with a small sample size. The following section will report mainly on 
quantitative results, with some supporting quotes (i.e. qualitative data) obtained from open-
ended responses in questionnaires.
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Table 3: Matched patient pre- and post-implementation questionnaires - Benefits  Total N=23   
  Pre- n (%) Post- n (%)  
Evaluation Question: Benefits SD/ 
Disagree  
Neutral Agree/ 
SA 
SD/ 
Disagree  
Neutral Agree/ 
SA 
Q1. Self-medicating in hospital may/has allow/ed me to be discharged sooner 8 (40%) 7 (35%) 5 (25%) 2 (10%) 9 (45%) 9 (45%) 
Q2. Self-medicating will/has improve/d my confidence in taking my medicines 2 (10%) 2 (10%) 16 (80%) 2 (10%) 7 (35%) 11 (55%) 
Q3. Using a blister pack may/has reduce/d the number of medications I miss or forget 1 (5%) 4(20%) 15 (75%) 3 (15%) 2 (10%) 15 (75%) 
Q4. Using  a blister pack may/has reduce/d medication errors (e.g. wrong drug, wrong dose) 
(n = 19) 
1 (5%) 7 (37%) 11 (58%) 2 (11%) 5 (26%) 12 (63%) 
Q5. Using a blister pack may/has improve/d my chances of staying independent at home for 
longer (n = 19) 
0 (0%) 7 (37%) 12 (63%) 1 (6%) 5 (26%) 13 (68%) 
Q6. Using a blister pack may/has save/d my nurse time on the medication round 2 (10%) 4 (20%) 14 (70%) 2 (10%) 4 (20%) 14 (70%) 
Q7. Self-medicating will/has improve/d my knowledge of my medication  (n = 19)  2 (10%) 3 (16%) 14 (74%) 1 (5%) 6 (32%) 12 (63%) 
Q8. Self-medicating will/has give/n me a sense of responsibility for my health care 1 (5%) 3 (15%) 16 (80%) 1 (5%) 3 (15%) 16 (80%) 
Q9. Self-medicating will/has increase/d my independence 1 (5%) 3 (15%) 16 (80%) 2 (10%) 5 (25%) 13 (65%) 
Q10. Self-medicating in hospital will/has make me feel trusted   (n = 19) 0 (0%) 7 (37%) 12 (63%) 2 (10%) 6 (32%) 11 (58%) 
Q11. Self-medicating has/may improve/d my relationship with my nurses and doctors (n = 19) 0 (0%) 11 (58%) 8 (42%) 2 (10%) 6 (32%) 11 (58%) 
Q12. Self-medicating with a blister pack will be/has been convenient 1 (5%) 4 (20%) 15 (75%) 2 (10%) 1 (5%) 17 (85%) 
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*Statistically significant difference (p = <0.05) 
 
 
 
 
 
Table 4: Matched patient pre- and post-implementation questionnaires (Neutral/Disagree combined) 
with p-values (Benefits) 
Total N=23   
 Pre- n (%) Post- n (%) P-value 
Evaluation Question: Benefits Neutral 
/Disagree/
SD  
Agree/SA Neutral/
Disagree
/SD  
Agree/SA  
Q1. Self-medicating in hospital may/has allow/ed me to be discharged sooner 15 (75%) 5 (25%) 11 (55%) 9 (45%) 0.04* 
Q2. Self-medicating will/has improve/d my confidence in taking my medicines 4 (20%) 16 (80%) 9 (45%) 11 (55%) 0.06 
Q3. Using a blister pack may/has reduce/d the number of medications I miss or forget 5 (25%) 15 (75%) 5 (25%) 15 (75%) 1.0 
Q4. Using  a blister pack may/has reduce/d medication errors (e.g. wrong drug, wrong dose) (n = 19) 8 (42%) 11 (58%) 7 (37%) 12 (63%) 0.71 
Q5. Using a blister pack may/has improve/d my chances of staying independent at home for longer (n = 19) 7 (37%) 12 (63%) 6 (32%) 13 (68%) 0.65 
Q6. Using a blister pack may/has save/d my nurse time on the medication round 6 (30%) 14 (70%) 6 (30%) 14 (70%) 1.0 
Q7. Self-medicating will/has improve/d my knowledge of my medication  (n = 19)  5 (26%) 14 (74%) 7 (37%) 12 (63%) 0.41 
Q8. Self-medicating will/has give/n me a sense of responsibility for my health care 4 (20%) 16 (80%) 4 (20%) 16 (80%) 1.0 
Q9. Self-medicating will/has increase/d my independence 4 (20%) 16 (80%) 7 (35%) 13 (65%) 0.18 
Q10. Self-medicating in hospital will/has make me feel trusted   (n = 19) 7 (37%) 12 (63%) 8 (42%) 11 (58%) 0.71 
Q11. Self-medicating has/may improve/d my relationship with my nurses and doctors (n = 19) 11 (58%) 8 (42%) 8 (42%) 11 (58%) 0.26 
Q12. Self-medicating with a blister pack will be/has been convenient 5 (25%) 15 (75%) 3 (15%) 17 (85%) 0.41 
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It can be seen that patients were more likely to agree that the system gave them the opportunity 
to be discharged sooner after their experiences with it. One quarter of patients (25%) initially 
agreed that the system would allow them to be discharged sooner, which increased with 
statistical significance to 45% post-implementation (p=0.04). A positive shift was also seen when 
patients were asked if they thought the blister pack system had improved their relationships with 
their nurses and doctors. Initially 42% thought the system would improve this relationship. This 
rose to 58% when asked post-implementation. One patient responded: 
“Interaction with my nurses often happens, which I appreciate” (P:20) 
 
Patients found the self-administration system very convenient; three quarters (75%) of patients 
initially agreed with its convenience, and this rose to 85% after their experiences with it. 
 
Conversely, some perceived benefits were found to decline post-implementation. Initially, four 
out of every five patients (80%) believed that self-administration would improve their confidence 
in taking their medications. However this declined to just over half the patients (55%) post-
implementation. Similarly, 80% of patients believed that self-administration would improve their 
independence; however this declined to 65% in the post-implementation questionnaire.  
 
Some perceived benefits remained unchanged when measured pre- and post-implementation. 
For example, 70% of patients believed that self-administration would save time for their nurses 
pre-implementation. This proportion remained at 70% of patients in agreement after 
experiencing the system. One patient stated that the system would be: 
“Less time consuming, not having to open several containers. It will be very helpful having 
it all in one place” (P:7)  
Similarly, 80% of patients believed that self-administration would give them a self of responsibility 
for their healthcare. This remained unchanged also. 
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Open-ended responses from questionnaires added richness to the data obtained from the Likert 
scales. Many patients expressed that the system gave them reassurance and peace of mind as 
demonstrated by these quotes: 
“Peace of mind is what I feel from using a blister pack” (P:17) 
 “Knowing when to take them is more comforting and accurate so medications take effect 
better” (P:17) 
 “I will not have to make sure I have up-to-date scripts” (P:13) 
“An excellent system that supports my self-confidence” (P:3) 
 
Patients were asked if they would like to self-administer their medication in hospital in the future. 
Seventy percent of patients responded that they would indeed like to self-administer in the 
future. 
 
6.1.2 Perceived Concerns – Patient Questionnaires (Quantitative Data 
Analysis) 
 
Quantitative data outlined in Tables 5 and 6 display the thoughts and perceptions of patients both 
pre- and post-implementation with regards to their concerns or worries about the system. Table 6 
shows p-values obtained using the McNemar-Bowker test of symmetry. Variables were 
dichotomised (i.e. columns combined) to increase the probability of obtaining statistically 
significant results.   
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Table 5: Matched patient pre- and post-implementation questionnaires - Concerns Total N=23    
  Pre- n (%)  Post- n (%) 
Evaluation Question: Concerns Disagree/SD  Neutral Agree/SA   Disagree/SD  Neutral SA/Agree 
Q13. I am concerned about the accuracy of medications in the blister pack 6 (30%) 7 (35%) 7 (35%) 12 (60%) 2 (10%) 6 (30%) 
Q14. I would rather/would have preferred to have a nurse give my medications ( n=18) 7 (39%) 11(61%) 0 (0%) 8 (45%) 4 (22%) 6 (33%) 
Q15. I am concerned that this service will/has increase/d the workload of the nurses (n=19) 9 (48%) 9 (47%) 1 (5%) 13 (68%) 3 (16%) 3 (16%) 
Q16. I am concerned that this service will be/has been time consuming for my nurse 11 (55%) 8 (40%) 1 (5%) 14 (70%) 2 (10%) 4 (20%) 
Q17. I am/was worried that my pack will/would not be updated if my medications change  8 (40%) 5 (25%) 7 (35%) 11 (55%) 4 (20%) 5 (25%) 
Q18. I am worried that I might take medicines from the wrong compartment  14 (70%) 5 (25%) 1 (5%) 16 (80%) 3 (15%) 1 (5%) 
Q19. I am worried about using a blister pack for medicines that need to be taken with special 
instructions, for example, with food or on an empty stomach   
7 (35%) 4 (20%) 9 (45%) 9 (45%) 4 (20%) 7 (35%) 
Q20. I am worried that I won’t have the strength to push the tablets out of the pack (n=19) 14 (74%) 3 (16%) 2 (10%) 10 (53%) 6 (31%) 3 (16%) 
Q21. I am worried about not recognizing the tablets in the pack 11 (55%) 7 (35%) 2 (10%) 15 (75%) 2 (10%) 3 (15%) 
Q22. I am/was worried that I will/would forget to ask the nurse for my medicines when they 
are due  
11 (55%) 6 (30%) 3 (15%) 14 (70%) 2 (10%) 4 (20%) 
Q23. I am worried about the tablets degrading in the pack (n=19) 17 (89%) 2 (11%) 0 (0%) 15 (78%) 2 (11%) 2 (11%) 
Q24. Nurses/ doctors might not/did not approve of me self-administering my medications in 
hospital 
12 (60%) 8 (40%) 0 (0%) 13 (65%) 6 (30%) 1 (5%) 
Q25. I am worried about paying for ongoing blister packs when I go home  14 (70%) 4 (20%) 2 (10%) 11 (55%) 2 (10%) 7 (35%) 
Q26. I am worried that the blister pack will be/is confusing 14 (70%) 6 (30%) 0 (0%) 16 (80%) 2 (10%) 2 (10%) 
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*Statistically significant difference (p = <0.05) 
 
Table 6:Matched patient pre- and post-implementation questionnaires 
(Neutral/Agree combined)  with p-values (Concerns) 
Total N=23   
 Pre- n (%) Post- n (%) P-value 
Evaluation Question: Concerns Disagree/SD  Neutral/Agree/
SA   
Disagree/SD  Neutral/Agree/ 
SA 
 
Q13. I am concerned about the accuracy of medications in the blister pack 6 (30%) 14 (70%) 12 (60%) 8 (40%) 0.03* 
Q14. I would rather/would have preferred to have a nurse give my medications      
(n=18) 
7 (39%) 11(61%) 8 (44%) 10 (56%) 0.56 
Q15. I am concerned that this service will/has increase/d the workload of the 
nurses (n=19) 
9 (47%) 10 (53%) 13 (68%) 6 (32%) 0.10 
Q16. I am concerned that this service will be/has been time consuming for my 
nurse 
11 (55%) 9 (45%) 14 (70%) 6 (30%) 0.26 
Q17. I am/was worried that my pack will/would not be updated if my medications 
change  
8 (40%) 12 (60%) 11 (55%) 9 (45%) 0.32 
Q18. I am worried that I might take medicines from the wrong compartment  14 (70%) 6 (30%) 16 (80%) 4 (20%) 0.32 
Q19. I am worried about using a blister pack for medicines that need to be taken 
with special instructions, for example, with food or on an empty stomach  
7 (35%) 13 (65%) 9 (45%) 11 (55%) 0.48 
Q20. I am worried that I won’t have the strength to push the tablets out of the 
pack (n=19) 
14 (74%) 5 (26%) 10 (53%) 9(47%) 0.10 
Q21. I am worried about not recognizing the tablets in the pack 11 (55%) 9 (45%) 15 (75%) 5 (25%) 0.10 
Q22. I am/was worried that I will/would forget to ask the nurse for my medicines 
when they are due  
11 (55%) 9 (45%) 14 (70%) 6 (30%) 0.08 
Q23. I am worried about the tablets degrading in the pack (n=19) 17 (89%) 2 (11%) 15 (78%) 4 (22%) 0.32 
Q24. Nurses/ doctors might not/did not approve of me self-administering my 
medications in hospital 
12 (60%) 8 (40%) 13 (65%) 7 (35%) 0.74 
Q25. I am worried about paying for ongoing blister packs when I go home  14 (70%) 6 (30%) 11 (55%) 9 (45%) 0.26 
Q26. I am worried that the blister pack will be/is confusing 14 (70%) 6 (30%) 16 (80%) 4 (20%) 0.41 
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It can be seen that patients became more trusting in the medication accuracy of their blister 
packs as they had experience with the system. The proportion of patients who were unconcerned 
about medication accuracy doubled from 30% to 60% post-implementation. This change reached 
statistical significance (p=0.03). Similar positive shifts were observed when patients were asked if 
they were worried that the system would increase the workload of the nurses or be time 
consuming for the nurses. Around half of the patients (53%) were initially concerned that the 
system would increase the workload of the nurses. At discharge, after experiencing the new 
system, only 32% remained concerned. The same trend was noted when patients were asked 
about their concern regarding the system being time consuming for nurses.  
Patients were seen to become more trusting that their blister packs would be updated in a timely 
manner if their medications were modified (40% to 55%). Tablet recognition was found to be less 
of a concern post-implementation. Fifty-five percent of patients disagreed that tablet recognition 
would be a problem pre-implementation, and this was found to rise to 75% post-implementation. 
Similarly, patients became less anxious about forgetting to ask their nurse when their medications 
were due (concern declined from 45% to 30%).   
 
Conversely, the proportion of patients who stated they preferred a nurse to give their 
medications in hospital rose (from 0% to 33%). Commonly, comments revolved around frustration 
that packs were required to be locked in patient drawers: 
“Can’t really self-medicate in hospital as the drawer where they are kept is locked” (P:17) 
“Nurse still had to come to give me the pills, waste of her time” (P:9) 
Some patients felt concerned about casual nurses not being familiar with the system: 
 “I felt that some nursing staff were confused and unfamiliar with the pack” (P:12) 
Also, patients were found to increasingly worry about having the strength to dispense tablets 
from the blister pack (10% to 16% of respondents). An administration aid, known as a Pil-Bob® 
was made available to appropriate patients to help pierce the blister foil backing. Some patients 
commented: 
 “Blister pack is hard to use, hard to cut out the back to empty the blister.” (P:9) 
“The difficulty of releasing tablets with my arthritic hands is a concern” (P:17) 
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Some perceived concerns remained relatively unchanged when measured pre- and post-
implementation. For example, it was consistently found that the majority (70-80%) of patients felt 
confident about taking their medications from the correct pocket of the blister pack.  Similarly, 
the majority (70-80%) disagreed that using a blister pack would cause confusion. Fifty-five to 
sixty-five percent of  patients were somewhat concerned, however, about packed medications 
that were required to be taken with specific instructions e.g. with food, empty stomach, etc. 
These themes remained consistent when pre- and post-implementation data were compared. 
 
6.1.3 Thematic Analysis of Patient Interviews (Qualitative Data Analysis) 
 
Of the twenty-three patients enrolled into the study, a total of twenty patients continued using 
the self-administration blister pack system up to the point of discharge. As a result, twenty 
patients completed the post-implementation interview conducted by the principle investigator. 
Five distinct themes were identified in the analysis of patient interviews.  These were that the 
system saved nurse time, accessing medication from the pack was found to be difficult, it 
improved patient confidence, was convenient and easy to use, and patients expressed concern 
about medication accuracy of packs on discharge. These themes will now be discussed in detail, 
supported with quotes from individual patients. Data was drawn from thematic (qualitative) 
analysis of patient interviews. Frequencies of responses have been calculated and quantified for 
ease of comparison.  
 
Major themes identified: 
 
1. The system saved time for nursing staff  
The majority (65%) of patients interviewed perceived that this self-administration system saved 
time on the medication round for nurses. Examples of patient remarks included: 
“I’ve watched them [nurses] before the blister pack rattle through the bottles and boxes 
and struggle to find the right medication and that takes four times longer than just 
popping open the pack” (P:2) 
and 
“It would be a terrific time-saver I would say” (P:17) 
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This theme, along with the large proportion of patients who voiced it, was found to be consistent 
with the quantitative data obtained from patient questionnaires.  
 
2. Accessing medication from the pack was difficult 
Six patients (30%) stated that physically accessing the tablets in the blister packs was difficult. A 
few patients expressed that patients with arthritis would really struggle with dispensing from the 
pack. Some remarked that occasionally tablets could get stuck behind the backing paper and 
remain in the pack unintentionally. One patient stated: 
“I think it would be very easy to lose some of the medicines because you’re trying to get 
them into a little cup and I think you could lose some” (P:12) 
The proportion of patients who identified this problem in the interviews (30%) was greater than 
those who expressed this problem in the questionnaires (10-16%). Hence the interviews have 
added extra richness to the data and have emphasised a problem which didn’t appear to be as 
significant from questionnaire data alone. 
 
3. Improved patient confidence 
Forty percent of patients suggested that the system improved their confidence with their 
medications and their ability to manage at home. Patients felt reassured that their medications 
were pre-packed and correct, reducing the risk of error. One patient stated:  
 “I like having the assurance that it’s all there and correct and I don’t have to make 
a mistake…” (P:17) 
and  
 “I have the greatest of confidence in my pharmacist…” (P:17) 
Another patient expressed their view: 
 “It gives me a sense of self sufficiency and I feel as though I am in charge, which is 
important for going home”. (P:2) 
This theme and the proportion of patients who agreed that the system improved confidence were 
consistent with the data from the post-implementation questionnaires.  
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4. Convenient and easy to use  
It was found that 30% of patients thought the self-administration system was convenient and 35% 
found the blister packs easy to use whilst in hospital. Some patients viewed the fact that their 
medicines would be organized in a weekly blister pack very positively. One patient stated: 
“My local chemist could do it [pack blister packs] at a minimal fee, which is convenient”. 
(P:1) 
and 
“I find it most convenient, I think it’s a good idea. A really good idea” (P:1) 
Patients commented on the ease of use of the system in the post-implementation interviews. 
Upon asking one patient how she found using the system, she remarked: 
“Absolutely beautiful, easy, I don’t have to think about it…if I missed this or I missed that”. 
(P:14) 
Another commented that it was simple for nursing staff: 
“It’s easy for them [nurses] because they just hand it to me and I just take them.” (P:13) 
The questionnaires were more successful at highlighting the theme of convenience. Whilst only 
30% of patients mentioned convenience in the interviews, 75% of patients agreed with its 
convenience in the questionnaires. 
 
5. Concern about accuracy of packs on discharge 
Two patients (10% of total) expressed some concern in regards to the accuracy of blister packs 
from their local chemist for when they are discharged home. They agreed that the system is 
beneficial for them as long as the medications are packed accurately. Specifically, one patient 
remarked that he had: 
“None [concerns] except that I’m hoping that my local chemist gets it right.” (P:2) 
Another made a similar remark: 
“As long as the chemist puts in everything in that he should put in, and everything’s there, 
it’s a fine way to do it.” (P:18) 
More patients expressed concern regarding medication accuracy in the questionnaires (30%) than 
in the semi-structured interviews (10%).  
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6.2 Nurse Perceptions  
 
Overall, the nurses perceived that the system allowed patients to be discharged sooner, that it 
was beneficial for patients, improved patient independence, and saved time. They did, however, 
express concerns about patients having the strength to access the tablets in the blisters, and were 
concerned about the possibility of patients taking medication from the wrong pocket. For some 
aspects, perceptions changed before and after experiencing the self-medication system. For a few 
aspects the changes in perceptions were statistically significant. These included perceptions of the 
system improving patient confidence, reducing medication errors, improving patient medication 
knowledge and being time consuming.  For other aspects trends in perceptions were noted.    
 
6.2.1 Perceived Benefits – Nurse Questionnaires (Quantitative Data 
Analysis) 
 
Results of quantitative data analysis displayed in Table 7 demonstrate the thoughts and 
perceptions of nurses both pre- and post-implementation with regards to the benefits that the 
system had delivered. This data was collected via the pre- and post-implementation nurse 
questionnaires. Open-ended questions were included in the questionnaire and responses 
analysed. P-values are displayed and were calculated using a 2-sample Z test for changes in 
proportions for the Agree/Strongly Agree responses. Variables were dichotomised (i.e. columns 
combined) to increase the probability of obtaining statistically significant results. The following 
section will report mainly on quantitative results, with some supporting quotes (i.e. qualitative 
data) obtained from open-ended responses in questionnaires.
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*Statistically significant difference (p = <0.05) 
Table 7: Nurse pre- and post-implementation questionnaires results using a 2-sample 
Z-test to compare nurse sample proportions (for SA/Agree)* (Benefits) 
n= 27 (1 missing for Q6) n= 32 (1 missing for Q1 & 7)  
 Pre- n (%)  Post- n (%) p-
value
* 
Evaluation Question: Benefits SD/ 
Disagree  
Neutral *SA/Agree SD/ 
Disagree  
Neutral *SA/ 
Agree 
 
Q1. Self-medicating in hospital may/has allow/ed patients to be discharged sooner 2 (7%) 11 (41%) 14 (52%) 2 (6%) 9 (29%) 20 (65%) 0.33 
Q2. Self-medicating may/has improve/d patient confidence in taking their medicines 0 (0%) 1 (4%) 26 (96%) 1 (3%) 6 (19%) 25 (78%) 0.04* 
Q3. Using a blister pack may/has reduce/d the number of medication omissions 1 (4%) 4 (15%) 22 (81%) 4 (13%) 10 (31%) 18 (56%) 0.04* 
Q4. Using  a blister pack may/has reduce/d medication errors (e.g. wrong drug, wrong 
dose) 
1 (4%) 4 (15%) 22 (81%) 3 (9%) 9 (28%) 20 (63%) 0.11 
Q5. Using a blister pack may/has improve/d patient chances of staying independent at 
home 
0 (0%) 1 (4%) 26 (96%) 1 (3%) 1 (3%) 30 (94%) 0.66 
Q6.  Using a blister pack may/has  save/d time on the medication round 2 (8%) 5 (19%) 19 (73%) 2 (6%) 7 (22%) 23 (72%) 0.92 
Q7.  Self-medicating  may/has  improve/d patient knowledge of their medications 2 (7%) 4 (15%) 21 (78%) 4 (13%) 14 (45%) 13 (42%) 0.01* 
Q8.  Self-medicating will/has give/n patients a sense of responsibility for their health 
care 
0 (0%) 1 (4%) 26 (96%) 1 (3%) 5 (16%) 26 (81%) 0.08 
Q9.  Self-medicating will/has increase/d patient independence 0 (0%) 2 (7%) 25 (93%) 1 (3%) 2 (6%) 29 (91%) 0.79 
Q10.  Self-medicating in hospital will/has make/made patients feel trusted   0 (0%) 12 (44%) 15 (56%) 1 (3%) 8 (25%) 23 (72%) 0.19 
Q11. Self-medicating will/has improve/d patient relationships with their nurses and 
doctors 
1 (4%) 16 (59%) 10 (37%) 2 (6%) 18 (56%) 12 (38%) 0.97 
Q12. Self-medicating with a blister pack will be/is convenient for patients 1 (4%) 2 (7%) 24 (89%) 2 (6%) 0 (0%) 30(94%) 0.50 
Q13. I believe that the service will/has benefit/ed patients 1 (4%) 6 (22%) 20 (74%) 1 (3%) 2 (6%) 29 (91%) 0.09 
Q14. Self-medication may/has allow/ed me to focus more time and energy on other 
clinical activities 
3 (11%) 9 (33%) 15 (56%) 3 (9%) 6 (19%) 23 (72%) 0.19 
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Twenty-seven nurses (68% of all nurses) completed a questionnaire pre-implementation and 32 
(80%) completed a questionnaire post-implementation.  Similar to patients, most nurses felt that 
this system would allow patients to be discharged sooner. The proportion in agreement rose from 
just over half (52%) of respondents pre-implementation to two-thirds (65%) of respondents post-
implementation. In a similar fashion, the proportion of nurses who felt that the system benefited 
patients rose from three quarters (74%) to 91% of respondents.  Some nurses stated: 
 “Patients feel they are involved in their care” (N:41) 
“Practicing self-medicating in hospital under supervision will make it easy for them when 
they go home” (N:41) 
 “I feel it is a positive initiative” (N:26) 
The majority of nurses felt that the system allowed them to focus more time and energy towards 
other clinical activities. One nurse stated that a benefit included: 
“No need for nurses to order medications. Pharmacist takes care of it” (N:18) 
 
Conversely, prior to implementation of the system, the vast majority of nurses felt that self-
administration would improve patient confidence with their medicines (96%) and reduce the 
number of medication omissions pre-implementation (81%). This proportion was seen to decline 
with a significant shift from Agree/Strongly Agree to Neutral (p=0.04 for both). There was an 18% 
drop in agreement regarding improving confidence and a 25% drop regarding reduction of 
medication omissions when comparing post-implementation results. A similar shift was seen 
when nurses were asked if the system would reduce medication errors. The same trend was 
noted regarding the system improving patient medication knowledge (from 78% to 42%, p=0.01). 
 
 
Some perceived benefits remained unchanged when measured pre- and post-implementation. 
For example, the vast majority of nurses agreed both pre- and post-implementation that the 
system improved patient independence (93% and 91% respectively) and allowed patients to stay 
independent at home for longer (96% and 94% respectively). One nurse stated that the system:  
 “Should improve independence for patients. Give them more control” (N:6)   
“Patients enjoy the medication round and are eager to improve their independence so that 
they can go home earlier” (N:28) 
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Similarly, the majority (73% and 72% respectively) felt that this system saved time on the 
medication round when asked pre- and post-implementation. Further, nurses felt the system was 
very convenient both pre- and post-implementation (89% and 94% respectively). One nurse 
stated that the system was: 
“Convenient in all areas for patients and staff” (N:6) 
 
6.2.2 Perceived Concerns – Nurse Questionnaires (Quantitative Data 
Analysis) 
 
Data displayed in Table 8 shows the thoughts and perceptions of nurses with regards to their 
concerns about the system. P-values were calculated using a 2-sample Z test for changes in 
proportions for the Disagree/Strongly Disagree responses. Again, variables were dichotomised to 
increase the probability of obtaining statistically significant results. 
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*Statistically significant difference (p = <0.05) 
Table 8: Nurse pre- and post-implementation questionnaires results using a 2-sample 
Z-test to compare nurse sample proportions (for SD/Disagree)* (Concerns) 
n= 27 (1 missing for Q26) n= 32 (1 missing for Q15, Q18 & 
Q19) 
 
 Pre-  n (%)  Post- n (%) p-
value 
Evaluation Question: Concerns  *SD/ 
Disagree  
Neutral SA/Agree *SD/ 
Disagree  
Neutral SA/Agree  
Q15. I am concerned about the accuracy of medications in the blister pack 8 (30%) 11 (40%) 8 (30%) 14 (45%) 6 (19%) 11 (36%) 0.22 
Q16. I would rather administer medications from bottles and boxes as usual 10 (37%) 12 (44%) 5 (19%) 12 (37%) 14 (44%) 6 (19%) 0.97 
Q17.  I am concerned that this service will/has increase/d my workload 11 (41%) 13 (48%) 3 (11%) 20 (63%) 8 (25%) 4 (12%) 0.09 
Q18.  I am concerned that this service will be/is more time consuming 11 (41%) 13 (48%) 3 (11%) 22 (71%) 7 (23%) 2 (6%) 0.02* 
Q19. I am worried that the pack will not be/is not updated if patient medications 
change 
4 (15%) 5 (18%) 18 (67%) 2 (6%) 7 (23%) 22 (71%) 0.30 
Q20. I am worried that patients might/do take medicines from the wrong 
compartment  
3 (11%) 7 (26%) 17 (63%) 5 (16%) 7 (22%) 20 (62%) 0.62 
Q21. I am worried about using a blister pack for medicines that need to be taken with 
special considerations e.g. with food or on an empty stomach  
3 (11%) 4 (15%) 20 (74%) 6 (19%) 5 (15%) 21 (66%) 0.42 
Q22.  I am worried that patients may not have the strength to push the tablets out of 
the pack 
4 (15%) 12 (44%) 11 (41%) 8 (25%) 3 (9%) 21 (66%) 0.33 
Q23.  I am worried about not recognizing the tablets in the pack to verify the correct 
medicines are given 
4 (15%) 7 (26%) 16 (59%) 10 (31%) 8 (25%) 14 (44%) 0.14 
Q24.  I am worried about the stability of the tablets in the pack 11 (41%) 11 (41%) 5 (18%) 19 (59%) 9 (28%) 4 (13%) 0.15 
Q25. I am worried that mandatory  requirements for medication administration 
outlined in policies and procedures do not support blister packs 
10 (37%) 9 (33%) 8 (30%) 14 (44%) 14 (44%) 4 (12%) 0.60 
Q26.  Blister packs may/do cause confusion among nursing staff 8 (31%) 11 (42%) 7 (27%) 18 (56%) 9 (28%) 5 (16%) 0.05 
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  Nurse confidence in the accuracy of packed medications was seen to  improve as time passed. 
Initially, 30% of nurses were confident in the accuracy of the blister packs, this rose post-
implementation to 45% of nurses. Experience using the system shifted nurse opinions in regards 
to it increasing workload or being time consuming; the majority of nurses came to disagree with 
these statements (41% to 63%, 41% to 71% p=0.02 respectively). Nurses became less concerned 
about the stability of medications in the pack (18% to 13% respectively). Initially, a third of nurses 
(31%) disagreed that blister packs cause confusion among nursing staff; this rose dramatically to 
56% of nurse respondents post-implementation. Nurses were seen to become less concerned 
(59% to 44% respectively) about recognizing and verifying medications in the pack as they got 
used to the system. Interestingly, nurses because less concerned (74% to 66% respectively) about 
using blister packs for medications which require special administration instructions e.g. with 
food, empty stomach, swallowed whole. They did, however, increasingly worry about patients 
having the strength to access the tablets in the blisters (from 41% to 66% respectively). An 
administration aid, known as a Pil-Bob® was made available to patients upon request to help 
pierce the blister backing. Some quotes regarding this included: 
“If packs had larger compartments and were easier to open benefits would be more 
apparent” (N:27) 
“One patient had trouble popping medication out” (N:6)  
“Tablets are hard to pop out” (N:1) 
“Some packs are too hard to open” (N:28) 
 
Some perceived concerns remained unchanged when measured pre- and post-implementation. 
For example, one fifth (19%) of nurses stated that they would rather administer medications from 
bottles as usual both before and after the implementation.  Further, the majority (62-63%) of 
nurses were concerned about patients taking medications from the wrong compartment of the 
blister pack both pre- and post- implementation. One nurse stated:  
“Patients tend to not check what medications are packed. I had a close call where a 
patient almost took medication from wrong pocket. Dangerous if patient is confused or 
has poor eyesight.” (N:18) 
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Open-ended responses were analysed and a common concern was expressed regarding the 
possibility of tablets falling to the floor. Some nurses remarked: 
“Concern regarding meds falling to floor and can’t reuse them. Can’t use next day’s doses 
as will cause confusion. Time consuming to repack blister pack” (N:18) 
“If tablets drop on floor need to ring pharmacist to replace” (N:18) 
Nurses felt that re-packing may be time-consuming. Nurses expressed that it would be 
inconvenient to ask the pharmacist to repack the blister pack. 
 
6.2.3 Thematic Analysis of Nurse Interviews (Qualitative Data Analysis) 
 
Thematic analysis of nurse interviews identified some similar themes to the patient interviews 
relating to the system having saved time, improved patient confidence and that some patients 
found accessing the medications to be difficult. Other themes were unique to the nurses’ 
perspective, which included that the system improved patient independence and concern was 
expressed regarding tablet identification and verification.  These themes will now be discussed 
with quotes from nurses to support the analysis. Data was drawn from thematic (qualitative) 
analysis of nurse interviews. Frequencies of responses have been calculated for ease of 
comparison.  
 
Major themes identified: 
 
 
1. The system saved time  
Eighty percent of nursing staff interviewed stated that this self-administration system saved time 
on the medication round. A frequent comment was that blister packs saved administration time 
since individual drugs were not required to be selected by the nurse and expiry dates did not 
need to be checked.  This was consistent with quantitative data obtained from nurse 
questionnaires. 
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2. Accessing medication from the pack was difficult 
Forty percent of nursing staff expressed that some patients found physically accessing the tablets 
in the blister packs to be difficult. Many required assistance from nursing staff to pop tablets out. 
An even larger proportion of nurses (66%) expressed this concern in the post-implementation 
questionnaires.  
 
3. Improved patient confidence 
From a nursing perspective, 90% of interviewed nurses supported the system overall and agreed 
that it helped to boost patient confidence for discharge:  
“I think it’s good for the patients, for their independence and medication management at 
home, because they’re used to doing it in hospital with nurse supervision. It gives them the 
confidence and the independence to do it at home.” (N:9) 
The interviews were seen to over-represent this theme compared  with questionnaires. Of the 
nurses who completed the post-implementation questionnaire, 78% agreed that the system 
improved patient confidence. The proportion of nurses who agreed with this theme was 90% 
from the interviews.  
 
4. Improved patient independence 
Seventy percent of interviewed nursing staff stated that the self-administration system supports 
and improves patient independence, both as an inpatient and on discharge. One nurse stated that 
self-administration allows: 
“…more self-autonomy and [allows patients to be] better equipped on discharge.” (N:1) 
Another nurse stated: 
“It empowers them, it’s familiar to them, they’re used to it.” (N:6) 
Some nurses alluded to the idea that this system allows them to judge when patients are ready 
for discharge and may allow some patients to be discharged earlier. One nurse stated:  
“Patients enjoy the medication round and are eager to improve their independence so that 
they can go home earlier.” (N:9) 
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This gives patients an incentive to use the system as a means of proving their readiness for home.  
The interviews were seen to underrepresent this theme compared to the questionnaires. Of the 
nurses who completed the post-implementation questionnaire, 91% agreed that the system 
improved patient independence. The proportion of nurses who agreed with this theme was 70% 
for the interviews.  
 
5. Concern with tablet identification and verification 
Forty percent of nursing staff interviewed mentioned they were concerned about identifying 
tablets in the pack and verification of medications. Nurses were required to check packed 
medications in order to sign the administration record on the medication chart. The main concern 
was that of identifying lost medications that might fall from the blister pack onto the floor or 
become lost in the patient’s bed linen. Another concern was the replacement of lost tablets, in 
particular those medications that were not imprest stock on the ward. One nurse expressed that 
non-imprest medications would be less familiar to the nursing staff and therefore harder to 
identify. Another nurse felt concerned about the idea of identifying and removing a ceased 
medication from the pack. These concerns were present even though nurses had been educated 
about, and were aware that, each blister pack included a description of each tablet on the back of 
the pack. This description stated tablet or capsule colour, shape and/or any special embossed 
symbol or markings to aid tablet identification and verification.  
Nurses were supported throughout the study and encouraged to raise any concerns with the 
principal investigator. It was reiterated throughout that pharmacy would repack blister packs if 
medications changed, and strategies were put in place to manage medication changes after hours 
and on weekends. This included reverting back to ward stock and loose tablets given by the nurse 
if needed or altering medications from the blister pack e.g. halving a packed tablet once popped 
out if the dose had halved (until the whole pack could be modified). Education continued 
throughout the study regarding how to identify and verify packed tablets via the list and tablet 
descriptions on the back of the pack. Solutions to losing tablets were discussed in the nurse 
education sessions (see Appendix 9: Questions/issues come across during nurse education pre-
implementation and their resolutions) and during the implementation, however this hypothetical 
situation did not  arise in practice during the study period.  
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These concerns were found to diminish when pre- and post-implementation nurse interviews 
were compared, however they were still present. This was consistent with quantitative data 
obtained from nurse questionnaires. 
 
6.2.4 Comparisons between Nurse Pre- and Post-Implementation 
Interviews and Questionnaires (Quantitative and Qualitative Data 
Analysis) 
 
Overall, similar themes were expressed by nurses when comparing the pre- and post-
implementation interviews. Some differences were noted, however. Eighty percent of nurses 
interviewed post-implementation expressed that some patients found it difficult to remove 
medications from the pack. This concern was not expressed pre-implementation. It only came to 
light after experience with the system. This proportion was higher than that collected in the nurse 
post-implementation questionnaires, whereby only 66% of nurses expressed this concern. 
Similarly, a larger number of nurses felt that the system improved patient independence when 
interviewed post-implementation. Specifically, 40% of nurses expressed this theme pre-
implementation. This rose to 100% of nurses post-implementation. In the questionnaires, this 
proportion remained >90% both pre- and post-implementation.  
Some consistent themes were  noted when comparing pre- and post-implementation nurse 
interviews. The same number of nurses felt that the system saved time when comparing pre- and 
post-interviews. This consistent pattern was also noted in the questionnaires. Concerns about 
tablet verification and identification were also equally represented in the interviews. The 
questionnaires, however, showed the concern of tablet identification to diminish by 15% (from 
59% to 44%) after experience with the system. Lastly, 90% of nurses interviewed (pre- and post-
implementation combined) expressed that the system improved patient confidence. This 
consistency was not reflected in the questionnaires, however, which showed that 96% of nurses 
agreed that the system would improve patient confidence pre-implementation, but dropped to 
78% post-implementation. 
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6.3 Pharmacist Perspective (Qualitative Data Analysis) 
 
A reflective diary was kept by the principal investigator (also the pharmacist) in which general 
issues and problems encountered during implementation were recorded (see Appendix 9). The 
following findings were drawn from thematic analysis of the principle investigator’s own reflective 
diary. This particular analysis was not independently evaluated by another party. 
 
The implementation of this self-medication system involved much trial and error, brainstorming 
and education for both staff and patients. Firstly, implementation involved consideration of 
logistical issues such as how blister packs would be ordered and supplied on an ongoing basis for 
recruited patients. This required some thought regarding prevention of medication omissions and 
late doses. Ideally, blister packs should not be delivered too far ahead of time, as multiple packs 
being available could cause confusion for nursing staff (especially those that are casual), along 
with patients. The decision was initially made to pack blister packs each Friday and deliver to the 
ward on Friday afternoons in order to have the medications ready to dispense on Monday 
mornings. This would ensure doses were not delayed. This was trialed for a few weeks, however, 
it was found to not suit the workflow of the pharmacy department, since Friday afternoons are 
typically very busy. After discussion with the packing pharmacy assistant and other pharmacy 
staff, a compromise was reached that blister packs would be packed by the pharmacy assistant on 
Thursdays and held in the pharmacy department to be delivered to the ward on Friday afternoons 
by the principal investigator.  This system worked very well and ensured medications were always 
available for patients to be dosed on time.  
 
Consideration also had to be given as to which medications would be suitable for inclusion in the 
blister packs and which may be unsuitable. Options were discussed with the pharmacy manager 
and decisions were made with the intention of making the medication round as easy as possible 
for the nursing staff, whilst keeping practice consistent. Practicalities were considered, such as 
dosage forms, variable dose medications, and cytotoxic medications, to name a few. Decisions 
were also made in order to align practice with the Medication Handling in NSW Public Health 
Facilities Policy Directive.(43) Further details of non-packed medications are specified in Section 
4.4.3 - Identifying Inappropriate Medications for Blister Packing. 
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Patient recruitment into the study was a challenging process for the pharmacist/principal 
investigator. It was found that approximately 40% of patients deemed suitable for self-medication 
were not receptive to the idea of taking their medicines independently under nurse supervision in 
hospital. Some patients were discouraged by the fact that they would be included in a study and 
had to sign a consent form to participate. Others wished to discuss the idea with their family or 
spouse prior to consenting. Of those patients who wished to discuss the self-administration 
system with family or consider it overnight, all declined the service when followed up the next 
day. Many of the patients who declined to participate voiced that they were confident with 
managing their medications themselves. It seemed as if patients perceived this offer as a sign that 
the pharmacist or medical team thought they  may be struggling with managing their medications 
independently. It was clarified by the pharmacist that this assumption was not correct on many 
occasions; however this strategy did not seem to improve recruitment numbers. 
 
Data collection was restricted to a certain time period in order to meet the deadline set for 
submitting this final thesis. Patients were recruited and data collected from mid-April to mid-
August 2015.  As a result of time constraints and challenges faced with recruitment, the target 
sample of thirty patients was not reached. A total of 23 patients started using blister packs during 
the study duration. Of these, 20 patients continued all the way through until discharge. Of the 
three that did not follow through, one was transferred to another hospital and discharged home 
from there, one refused to use the packs, and another was discharged in a hurry and refused to 
wait to have his post-implementation data collected (i.e. patient post-implementation 
questionnaire and patient post-implementation interview). Numerous attempts were made to 
follow up with the patient that refused to wait to have his post-implementation data collected, 
however he was not able to be contacted post discharge.   The aforementioned time constraints 
along with patient recruitment difficulties were thought to be the reason behind a smaller than 
expected sample size for the study.  
 
Another factor documented in the principal investigator’s reflective diary that affected sample 
size was the minimal input from the multidisciplinary team with regards to nominating suitable 
patients.  The agreement reached was that the multidisciplinary team would discuss suitability of 
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patients for self-administration at the weekly case conference meetings; they would then notify 
the principal investigator of suitable patients, who would speak to the patient about participating 
in the study. The principal investigator, however, often had to directly prompt the Nurse Unit 
Managers (NUMs) to    review which patients  might be suitable and recommend study 
candidates. Often the NUMs would state that they had forgotten to discuss patient suitability for 
the study in the case conference.  The principal investigator then began reminding the NUMs to 
consider patients for the study before each case conference so that it would be fresh in their 
memories. This did help somewhat, however minimal numbers of patients were considered 
suitable by the team for various reasons. Most commonly, this was due to patients not satisfying 
the inclusion criteria.  
 
 Yet another factor affecting sample size documented in the reflective diary was that many 
patients were nominated as appropriate for the study too close to their discharge date. Ideally 
patients should have one or two weeks to practice using the blister pack before discharge. Often 
patients were nominated less than five days prior to discharge. The decision was made by the 
principal investigator for these particular patients to not include them in the study, as there was 
not enough time to ensure confidence and competence with the blister packs prior to discharge. 
This was considered an inappropriate risk for the patients.   
 
As previously mentioned, a pharmacy assistant was responsible for packing the blister packs and a 
registered pharmacist was required to check these packs to ensure medication accuracy before 
they were released. Any errors in packing were recorded on an error record sheet (see Appendix 
8). The record sheet documented a description of the error, how it was corrected or overcome 
and strategies put in place after the fact in order to prevent errors from reoccurring.  
 
The principal investigator’s reflective diary was also used to record interesting questions asked by 
nurses during the pharmacist-led education sessions provided before implementation, and their 
resolutions. Challenges regarding patient recruitment were recorded, along with the numbers of 
patients who were deemed suitable for the trial by the multidisciplinary team but did not 
participate.   Reasons for non-inclusion were noted, whether this was due to patients refusing to 
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participate, or due to the patient being deemed inappropriate by the investigator according to 
inclusion criteria. Packing errors and problems were also noted in the reflective diary; these 
included accuracy errors along with problems in relation to administration times of medications. 
Resolutions for these problems were recorded (see Appendix 9). 
  In this particular rehabilitation setting, it was found that from a population of up to 64 patients, 
the number of patients using this system at any one time varied from 2-6 patients. This 
proportion will differ in other rehabilitation centres and will be dependent on the total number of 
patients in the centre, the types of patients cared for and their suitability for participation in such 
a program.  
 
7. Discussion 
 
The results have demonstrated a variety of perceived benefits and concerns expressed by nurses 
and patients regarding the self-medication system. Trends and patterns in thoughts and opinions 
expressed at the pre-implementation and post-implementation time points have been noted. The 
pharmacist’s perspective expressed challenges encountered in the implementation of the system 
and how problems were resolved. The following section will discuss the meaning of the gathered 
results, compare and contrast nurse, patient and pharmacist perspectives and link these to what 
is known in the literature. Recommendations for setting up a similar system  are discussed, along 
with study limitations and directions of future research. 
 
7.1 Patient Perspective 
 
The findings from the questionnaires revealed a statistically significant rise in the number of 
patients that believed that self-medicating would allow them to be discharged sooner. This 
suggested that the system gave patients a means by which to prove their medication 
management abilities to medical and nursing staff whilst in hospital. This in turn could have been 
used as evidence to demonstrate patient readiness for discharge.  
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Questionnaire data revealed a drop in patient belief that self-administration improves their 
confidence in taking their medication. This was somewhat surprising since a review of the 
literature found that the majority of patients believe that self-medicating improves their sense of 
confidence and control.(9-19, 22) Supplementary data obtained from interviews suggested this 
observed trend was due to patients not having access to their medications in hospital, and being 
reliant on the nurse unlocking their drawer to take their medications.  
Patient interviews added richness to the questionnaire data obtained and allowed patients to 
express their true experiences and opinions of the system over and above what could be captured 
in the questionnaires. Interview data demonstrated that two fifths of patients did in fact report 
increased confidence in relation to medication management.  
 
A downward trend was noticed when comparing how patients felt the self-administration system 
affected  their independence (from pre- to post-implementation). When patient interview 
responses were considered, this trend could be explained by patients feeling they were still 
reliant on the nurses in hospital as blister packs were locked away. This reduced their feelings of 
independence in hospital, as captured in the questionnaires.  Hence it is clear that qualitative data 
from the interviews allowed for a deeper understanding of the trends observed in the 
quantitative questionnaire data.  
 
Overall, patients seemed to grasp the new system well and incorporate it into their routine in 
hospital. They felt the system gave them confidence and reassurance about their medications for 
discharge. They found the system convenient, however expressed frustration regarding 
difficulties opening the packs and having the packs locked away.  
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7.2 Nurse Perspective 
 
From questionnaires and interviews of nurses it was apparent that nurses increasingly believed 
over time that self-administration could lead to patients being discharged sooner. This trend is 
thought to be an indication that nurses felt that self-administration aided the multidisciplinary 
team in gauging patient readiness for discharge. The system allowed patients to prove their 
medication management abilities.  
 
Somewhat surprisingly, the number of nurses who felt that self-administration would improve 
patient confidence and reduce the number of medication omissions was found to decline post-
implementation. Drawing from data collected in the nurse post-implementation interviews, it is 
thought that this trend may be a result of some nurses feeling that blister packs may reduce 
patient knowledge of their medication, as they don’t have to think for themselves about which 
medications are due at each time point, since they are already packed in the correct pockets. This 
attitude was also captured in the nurse questionnaires, whereby a significant shift was seen from 
agreeing that medication knowledge would improve, to neutral. This is an example of how the 
interviews have added depth to the data and have allowed clear links to be made. Further, some 
nurses felt that blister packs may not necessarily reduce medication omissions if patients are not 
cognitively aware of what day it is or what time of the day it is. These patients would need 
prompting to take their medicines from a blister pack. This explanation was obtained from nurse 
interviews, reiterating the value that the interviews have brought to the data interpretation.  
 
 
Similar studies on self-administration contrasted with these perceptions. There is evidence from a 
number of studies that these programs provide benefits such as improved medication knowledge 
and confidence.(1, 2, 9-19, 22) These studies, however, did not use blisters packs for self-
administration. Further research is needed regarding self-administration with blister packs to 
either support or refute these perceptions.  
 
 
Another negative shift was observed when nurses were asked if they thought the self-
administration system would reduce patient medication errors. That is, a greater number of 
52 
 
nurses agreed that this system would reduce medication errors pre-implementation compared to 
post-implementation. It is clear from questionnaire data that some nurses were concerned about 
the accuracy of the blister packs. It is possible that nurses may be concerned about medication 
accuracy when packs are assembled or alternatively they may be worried that patients may take 
medications from the incorrect pocket. The fact that concerns about medication accuracy in the 
packs declined over time is an indication that nursing staff became more trusting of the pharmacy 
service during the trial period. This type of system allows for greater collaboration and teamwork 
to occur between pharmacy and nursing staff. The implementation of this system has been a 
learning experience for both nursing and pharmacy staff, and has built stronger relationships 
between members of the multidisciplinary team.  
 
The observed positive shifts in opinions regarding the system benefiting patients and allowing 
nurses to focus on other clinical activities were reassuring. These effects were predicted before 
the system was implemented, and are a positive sign. Further, the majority of nurses agreed that 
the system reduced their workload and saved time. These were some of the objectives of the self-
medication system. It was encouraging to see that some of these objectives had been successfully 
met.  
 
7.3 Pharmacist Perspective 
 
The pharmacist felt that this system would help the multidisciplinary team  determine when a 
patient would be safe for discharge home in regards to their medication management. The 
system could potentially allow patients to be discharged sooner, since blister packs take some 
pressure off patients getting their medications correct. Blister packs can also be a good indicator 
to the patient or their carers as to if medications have been omitted or forgotten. The pharmacist 
felt unconcerned about patients taking medications from the wrong compartment since only alert 
and orientated patients were initiated on blister packs, therefore risk of this type of error would 
be small.  
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It was anticipated that this system would improve patient confidence whilst they were inpatients 
as well as on discharge. Each blister pack came with an attached list of packed medications, 
including a description of each tablet’s appearance, the indication for each drug, the number of 
tablets packed and frequency each drug should be taken. The idea of this was so that patients 
could become familiar with each medication, including its use and appearance. This was predicted 
to enhance patient confidence.   
 
Accuracy of blister packs was a small concern initially since the pharmacy assistant was not 
familiar with the packing process. Blister packs were checked by a pharmacist before being 
released to minimise errors. As time passed this concern was diminished. Further, only a handful 
of errors were noted for the duration of the project (See Appendix 8). These were corrected 
before reaching the patient and steps were put in place to reduce the risk of reoccurrence.  
 
Difficulties encountered included patient recruitment challenges, time constraints and patients 
being nominated too close to discharge. Further details are outlined in 6.3 Pharmacist Perspective 
and Appendix 9: Reflective Diary. One major challenge experienced during this project was the 
minimal input from the multidisciplinary team with regards to nominating suitable patients. As 
discussed, the multidisciplinary team was slow to warm to the idea of patient nomination at the 
weekly case conference meeting. Reasons given for this included that the team felt they didn’t 
have time to perform this extra task each meeting. Other times, it was a matter of lack of 
preparation and lack of consideration of appropriate patients prior to the meeting. Other 
explanations were that the inclusion criteria was too narrow or that the team wasn’t sure about 
certain selection criteria for particular patients e.g. unsure about cognitive function, unsure if 
patient has a carer or family member to help with medications etc. Although the principal 
investigator   thought carefully about potential patient participants and approached those 
patients for recruitment, it was felt that the sample size of the study would have been boosted if 
there had been a consistent team approach employed.  
 
Overall, from the pharmacist’s perspective, the system was felt to be very convenient for both 
patients and nurses, and saved nurse time on the medication round. It was noted to be beneficial 
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for patient morale and confidence on discharge.  It was rewarding to be involved in the 
implementation of such a beneficial system.  The pharmacist felt reassured that on discharge, 
patients would be able to manage their medications easily and safely. This is important as 
medication errors and adverse events often occur during transition periods such as discharge 
from hospital.   
 
7.4 Comparisons of Perspectives  
 
All personnel involved in the project (i.e. the patients, nurses and pharmacist) were found to 
increasingly believe over time that self-medication had led to patients being discharged sooner. 
This trend was thought to be an indication that the system was useful in demonstrating patient 
readiness for discharge. The system allowed patients to prove their competence in managing their 
medications. This is an important consideration for a successful discharge.  
 
Perspectives collected showed that contrary to pharmacist predictions, patients and nurses did 
not feel that the system improved patient confidence whilst they were inpatients. Nurses felt that 
medication knowledge may decline if patients do not have to think about which medicines to 
select and take from boxes. Patients felt frustrated by having their medications locked away and 
being reliant on nurses to hand over their blister pack. Whilst confidence was seen to decline for 
inpatients, all involved believed that the system would improve patient confidence on discharge. 
These perceptions differed to those in published studies, in which confidence was observed to 
improve in self-medicating inpatients.(9) It’s possible that the use of blister packs, as opposed to 
loose bottles and boxes as per other studies in the literature(9), may have influenced these 
perceptions. Drawing from this idea, it’s predicted that blister packs for self-administration may 
be more useful if accompanied by education about the packed medications.(9) Patients would 
prefer if packs were not locked away, however to abide by the NSW Ministry of Health Policy 
Directive: Medical Handling in NSW Public Health Facilities(43), all medications must be stored in 
locked cupboards with restricted access by authorised staff members.  Hence, in this setting, it 
was mandatory to have packs out of patient access.  
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The accuracy of medications in the pack was seen to become less of a concern as time passed for 
all involved. Initial skepticism is to be expected with the introduction of any new system. At first, 
people tend to be overly cautious until they gain positive experiences with the system and find it 
to be reliable. Similarly, patients and nurses became more confident in identifying tablets in the 
pack, and were found to gain trust in the accuracy of the blister packs. This was seen as a positive 
sign moving patients towards improved medication knowledge and satisfaction with the system. 
 
Patient and nurse interviews suggested that patient independence had improved with the use of 
the blister pack system; however questionnaire data showed a drop in perceived independence. 
The reason for this inconsistency was that patients felt they were reliant on the nurses to give 
them their medications, as blister packs were locked away. This in turn reduced their feelings of 
independence in hospital.  However, patients and nurses felt that on discharge the blister packs 
would improve patient independence. Hence, it was deduced that having the blister packs locked 
away had adversely affected the patients’ perceptions of the system. 
 
All perspectives collected from patients, nurses and the pharmacist agreed that the system was 
convenient and saved time for nursing staff. This was an expected outcome due to the design of 
the system and having the medication at hand at all times. Numerous nurses stated that blister 
packs saved time finding and ordering medications from pharmacy, and nurses were content that 
they did not need to check expiry dates for packed medications. This was by far the most agreed 
upon benefit of the self-medication system. Other studies drew similar conclusions(9, 12) and 
found that initially setting up the system required a time investment, however this led to time 
savings in the long run.(31-37) 
 
A major concern for both nursing staff and patients was the difficulty experienced by some 
patients in  removing medications from the pack. This theme was expressed in both interviews 
and questionnaires. This concern emphasised the importance of testing blister pack materials 
with the target population before deciding on a supplier.  An administration aid, known as a Pil-
Bob®, was made available to patients upon request to help pierce the blister backing. These aids 
were supplied by the pharmacist in response to feedback from patients and nurses.  
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The majority of nurses felt concerned about the potential for patients to take medication from 
the wrong compartment of the blister pack. Conversely, only 5% of patients felt this may be a 
concern and the pharmacist was unconcerned. It was concluded that some nurses felt the self-
medication system was taking a bit of control from them and giving it back to the patient. It is 
thought that this small loss of control had put some nurses out of their comfort zone. This may 
explain why about a fifth of nurses maintained that they would have preferred to give 
medications themselves from bottles as usual practice over using blister packs.  
 
7.5 Comparison with the Literature   
 
This study has confirmed some of the findings from other published studies and has added new 
knowledge to that found in the literature. Numerous studies have found that between 76-100% of 
patients who have experienced self-administration prefer it compared with nurse administration 
and would choose to self-administer in the future.(10-13, 18-22) Comparable results were found 
in this study. Similarly, literature reviews have found that the majority of these patients prefer 
self-administration as it saves nurse time.(10-13, 18, 19, 28)  This is also consistent with the 
findings of this study.  
 
This particular self-medication system was unique as it used blister packs as a means to deliver 
medication to patients. Medications not appropriate for packing were self-administered by the 
patient under nurse supervision. This type of system had not been evaluated in published 
literature previously. Hence, this project adds a different perspective to the data in published 
literature regarding self-medication programs. Another unique addition is that of the pharmacist’s 
perspective in the implementation and evaluation of such a system. This perspective is lacking in 
many published studies. This study documented the pharmacist’s challenges regarding patient 
recruitment, motivating the multidisciplinary team to embrace the vision, and problem solving 
with regards to administration timing.  
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Unique perceptions were collected in this study which had not been previously explored in 
published studies with regards to self-medication systems. As discussed previously, these 
perceptions related to a range of benefits and concerns. New data was collected regarding the 
following themes: 
- Self-medicating was perceived to reduce time to discharge 
- Patients felt the system improved confidence and independence on discharge but not as 
inpatients 
- Patients felt reassurance and reduced pressure to manage their medications on discharge  
- Nurses believed that the system did not necessarily improve patient knowledge of 
medication 
- Nurses were consistently worried about patients taking medication from the wrong  
compartment 
- The system allowed nurses to focus more time on other clinical activities 
-  Removing medication from packs was found to be difficult for some patients  
 
7.6 Recommendations for Setting up a Self-Medication System 
 
After experience with the design and implementation of this blister pack self-medication system, I 
would recommend the following to anyone interested in setting up a similar system: 
- Choose patients carefully i.e. cognitively intact, motivated, stable medication regime, 
eager to learn about their medications, alert and orientated. 
- Obtain adequate support and buy-in from the multidisciplinary team. They can assist with 
patient nomination and market the service to patients. 
- Test blister packs on the target population including osteoarthritis sufferers to ensure 
they can pop out the tablets. Use a soft backing or obtain a device to help patients open 
the blisters e.g. Pill-Bob®.   
- Provide education for each patient about their medications, their indications and side 
effect profiles (nurse or pharmacist-led). 
These suggestions may be useful for the future implementation of a successful blister pack self-
administration scheme in another rehabilitation facility or hospital.  
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7.7 Limitations of Study and Recommendations for Future Research 
 
An identified limitation of this research project was the small sample size obtained. The aim was 
to recruit thirty patients, however, time constraints, resistance of patients to consent and  limited 
support from the multidisciplinary team resulted in a smaller than expected sample of twenty. 
Due to this, only a few findings produced statistically significant results (See 4.3.3 Statistical 
Analysis and section 6. Results for more information). 
 
Semi-structured interviews were conducted to add richness to the quantitative questionnaire 
data and explore ideas beyond what was expressed in the surveys. The scope of the project and 
time frame did not allow for transcription of all interviews. In order to minimise investigator bias, 
a selection of eight interviews (from a total of thirty) were independently evaluated by the 
University supervisor and pharmacy intern to ensure validity of themes and findings reported. 
 
Further research is required in other settings and with a greater number of study participants 
before the results of this study can be generalised. It would be recommended that this study be 
repeated with a larger sample size and over a longer duration in order to compare results and 
analyse trends. Complete transcription of interviews may aid qualitative data analysis. Future 
studies could consider adding an educational component for patients and measuring patient 
knowledge of their medications pre- and post-implementation. It may be beneficial for future self-
administration programs to invest more time in educating and promoting the service to the 
multidisciplinary team in order to achieve better support and buy-in from key stakeholders. 
Further, it would be useful to compare patient satisfaction in a setting where blister packs were 
freely accessible to patients at all times.  
 
Future related research projects could add depth to published literature on self-medication 
systems. Suggested questions to be answered include: Do self-medication programs improve 
adherence in poor compliers? Do self-medication programs teach patients about their medicines 
more effectively than counseling? What resources are required to implement and maintain a self-
medication program using blister packs? Future self-medication projects might consider follow-up 
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with patients at home following discharge to gather data about patient and carer satisfaction with 
blister packs, problems encountered and perceived effects on patient confidence and 
independence. 
Hence, there are still many more avenues to explore and questions to answer regarding self-
medication systems, particularly those involving blister packs.  
 
8. Conclusion   
 
This project has achieved success in the implementation of a self-medication system using blister 
packs in the Graythwaite Rehabilitation Centre of Ryde Hospital.  Foundations have been laid and 
processes have been put in place to continue this system for appropriately selected rehabilitation 
candidates.   
 
The aim of the research was also to evaluate and compare nurse, patient and pharmacist opinions 
and perceptions of the system pre- and post-implementation. The perceptions of each 
stakeholder have been analysed and discussed. From the findings of this research, it is clear that 
this system provides many benefits to patients and nurses alike. The system is not faultless, 
however, and concerns and suggestions for improvement have been collected and considered for 
future enhancements. Results and conclusions from this study will be disseminated to staff in the 
Graythwaite Rehabilitation Centre to inform them of the results of their efforts and obtain more 
feedback and suggestions of ways in which the system can be improved. This study has added a 
range of unique perceptions to what is already known about self-administration systems. It is 
hoped that publication of this study will inspire other services to initiate such a system and 
publish their experiences in order to build on the data available.  
 
In conclusion, this self-medication system is judged to have been successful in fulfilling its aims. 
Lessons have been learnt along the way, and I hope to be able to benefit and inspire other 
services wishing to implement such a system. These types of self-medication systems are ideal for 
rehabilitation units, and are the way forward in the pursuit of better patient outcomes.   
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Appendix 1: Patient and Nurse Information Sheets and Consent Form 
 
 
 
 
 
Graythwaite Rehabilitation Centre 
Ryde Hospital 
 
PATIENT PARTICIPANT INFORMATION SHEET AND CONSENT 
FORM 
 
Implementation and Evaluation of a Self-Medication System involving 
Blister Packs in the Graythwaite Rehabilitation Centre 
 
Invitation 
You are invited to participate in a research study looking at the benefits and 
concerns regarding self-administration of medications in hospital. 
 
The study is being conducted by Luiza Bozianu, the clinical pharmacist of 
Graythwaite Rehabilitation Centre. 
 
Before you decide whether or not you wish to participate in this study, it is 
important for you to understand why the research is being done and what it will 
involve. Please take the time to read the following information carefully and 
discuss it with others if you wish. 
 
1. ‘What is the purpose of this study?’ 
The purpose of this study is to introduce a system where some patients are able to 
take their medicines on the ward themselves from a blister pack under nurse 
supervision. A blister pack contains seven days of medications packed in pockets 
which can be pushed out and taken at the appropriate time of day and day of the 
week. Blister packs would continue to be used when you are discharged from 
hospital to help you with your medicines. 
 
2. ‘Why have I been invited to participate in this study?’ 
You are eligible to participate in this study because you take five or more 
medications and you will be managing your medications yourself when you are 
discharged. 
 
3. ‘What if I don’t want to take part in this study, or if I want to withdraw 
later?’ 
Participation in this study is voluntary. It is completely up to you whether or not you 
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participate. If you decide not to participate, it will not affect the treatment you 
receive now or in the future. Whatever your decision, it will not affect your 
relationship with the staff caring for you. 
 
If you wish to withdraw from the study once it has started, you can do so at any 
time without having to give a reason. 
 
4. ‘What does this study involve?’ 
If you agree to participate in this study, you will be asked to sign the Participant 
Consent Form. 
 
Your involvement in the study will include taking your prescribed tablets from a 
blister pack under nurse supervision. Other medications that cannot be packed 
(e.g. medications that require storage in the safe, as required medications, insulin, 
inhalers, patches etc.) will be given to you as usual under nurse supervision or 
administered by the nurse. Blister packs will be continued when you leave hospital 
and provided via your local chemist. You may only take your regular tablets from 
the blister pack provided by the hospital. 
 
Taking part won’t involve any changes to the medicines you are prescribed. 
 
You will be asked to fill in a questionnaire before you start using a blister pack  
regarding your thoughts and opinions of the service. Close to discharge, you will 
be asked to complete this questionnaire again as feedback and answer some 
questions about your experience of the service with the pharmacist. The 
questionnaires and interview will take 5-10 minutes each to complete. 
 
5. ‘What are the alternatives to participating in this study?’ 
If you decide not to participate in this study, your medicines will be provided to you 
in the normal way whilst you are in hospital. 
 
6. ‘Are there risks to me in taking part in this study?’ 
As your medications will be unchanged and only the way they are packaged and 
delivered will change, we do not believe that there are any risks to you should you 
decide to take part. 
 
7. ‘Will I benefit from the study?’ 
This study may benefit you by helping to improve your confidence in managing 
your medications at home and will hopefully reduce medication errors. 
 
8. ‘Will taking part in this study cost me anything, and will I be paid? 
The study is being funded by the pharmacy department of Ryde Hospital. 
Participation in this study will not cost you anything. However, once you are 
discharged you will be required to pay for the ongoing supply of blister packs from 
your nominated chemist. 
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9. ‘How will my confidentiality be protected?’ 
Of the people treating you, only the pharmacist, your treating doctors and nursing 
staff involved in your care will know whether or not you are participating in this 
study. Any identifiable information that is collected about you in connection with 
this study will remain confidential and will not be disclosed. Only the researcher 
named above and doctors and nurses directly involved with your care will have 
access to your details that will be held securely in the Pharmacy Department of 
Ryde Hospital. 
 
10. ‘What happens with the results?’ 
If you give us your permission by signing the consent document, we plan to 
discuss/publish the results of the study as part of a Master of Clinical Pharmacy 
Thesis and potentially present the results at a conference and/or publish results in 
a journal. In any publication, information will be provided in such a way that you 
cannot be identified. 
 
11. ‘What happens to my treatment when the study is finished?’ 
Continued supply of blister packed medication by the hospital will not be available 
after you are discharged from hospital. You may continue receiving blister packed 
medications if your nominated pharmacy agrees to provide this service. You will 
be required to pay for this service. The pharmacist will help you organise this 
service upon discharge. 
 
12. ‘What should I do if I want to discuss this study further before I decide?’ 
When you have read this information, the researcher Luiza Bozianu will discuss it 
with you and any queries you may have. If you would like to know more at any 
stage, please do not hesitate to contact her by notifying your nurse. 
 
13. ‘Who should I contact if I have concerns about the conduct of this 
study?’ 
This study has been approved by the Northern Sydney Local Health District 
HREC. Any person with concerns or complaints about the conduct of this study 
should contact the Research Office who is nominated to receive complaints from 
research participants. You should contact them on 02 9926 4590 and quote HREC 
reference number LNR/15/HAWKE/28. 
 
This study adheres to the Guidelines of the ethical review process of The 
University of Queensland and the National Statement on Ethical Conduct in 
Human Research. Whilst you are free to discuss your participation in this study 
with project staff (contactable on (02) 98587513), if you would like to speak to an 
officer of the University not involved in the study, you may contact the Ethics 
Coordinator on (07) 3365 3924. 
 
Thank you for taking the time to consider this study. 
If you wish to take part in it, please sign the attached consent form. 
This information sheet is for you to keep. 
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Graythwaite Rehabilitation Centre 
Ryde Hospital 
 
CONSENT FORM 
INTERVENTIONAL STUDY 
Implementation and Evaluation of a Self-Medication System involving 
Blister Packs in the Graythwaite Rehabilitation Centre 
 
1. I,................................................................................................................. 
of................................................................................................................  
agree to participate as a subject in the study described in the Participant Information 
Sheet set out above. 
 
2. I acknowledge that I have read the Participant Information Sheet, which explains 
why I have been selected, the aims of the study and the nature and the possible risks 
of the investigation, and the statement has been explained to me to my satisfaction. 
 
3. Before signing this consent form, I have been given the opportunity of asking any 
questions relating to any possible physical and mental harm I might suffer as a result 
of my participation and I have received satisfactory answers. 
 
4. I understand that I can withdraw from the study at any time without prejudice to my 
relationship to the investigators, or Ryde Hospital. 
 
5. I agree that research data gathered from the results of the study may be published, 
provided that I cannot be identified. 
 
6. I understand that if I have any questions relating to my participation in this research, 
I may contact Luiza Bozianu (Graythwaite Pharmacist) who will be happy to answer 
them. 
 
7. I acknowledge receipt of a copy of this Consent Form and the Participant 
Information Sheet. 
 
Complaints may be directed to the Research Office on Level 13, Kolling Building, 
Royal North Shore Hospital, St Leonards NSW 2065 
Phone 02 9926 4590 | email NSLHD-research@health.nsw.gov.au 
 
Signature of participant   Please PRINT name   Date 
_______________________________________________________________ 
 
Signature of witness   Please PRINT name   Date 
 
 
Signature of investigator  Please PRINT name   Date 
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Graythwaite Rehabilitation Centre 
Ryde Hospital 
 
INTERVENTIONAL STUDY 
 
Implementation and Evaluation of a Self-Medication System involving 
Blister Packs in the Graythwaite Rehabilitation Centre 
 
 
 
REVOCATION OF CONSENT 
 
I hereby wish to WITHDRAW my consent to participate in the study described 
above and understand that such withdrawal WILL NOT jeopardise any treatment 
or my relationship with the Graythwaite pharmacist / researcher or my medical 
attendants. 
 
Signature        Date 
 
Please PRINT Name 
 
The section for Revocation of Consent should be forwarded to: 
 
Ms Luiza Bozianu 
Graythwaite Clinical Pharmacist 
Pharmacy Department 
Ryde Hospital 
Denistone NSW 2114 
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Graythwaite Rehabilitation Centre 
Ryde Hospital 
 
NURSE PARTICIPANT INFORMATION SHEET AND CONSENT 
FORM 
Implementation and Evaluation of a Self-Medication System involving 
Blister Packs in the Graythwaite Rehabilitation Centre 
Invitation 
You are invited to participate in a research study looking at the benefits and 
concerns regarding self-administration of medications in hospital.  
The study is being conducted by Luiza Bozianu, the clinical pharmacist of 
Graythwaite Rehabilitation Centre. 
Before you decide whether or not you wish to participate in this study, it is 
important for you to understand why the research is being done and what it will 
involve. Please take the time to read the following information carefully and 
discuss it with others if you wish. 
1. ‘What is the purpose of this study?’ 
The purpose of this study is to implement a system where select patients are able 
to take their medicines on the ward themselves from a blister pack under nurse 
supervision. Blister packs will continue to be used when patients are discharged 
from hospital. Your opinions, perceptions and concerns about the new service will 
be sought both pre- and post-implementation.  
 
2. ‘Why have I been invited to participate in this study?’ 
You are eligible to participate in this study because you are a regular nursing staff 
member of Graythwaite Rehabilitation Centre and will be involved in this service.  
 
3. ‘What if I don’t want to take part in this study, or if I want to withdraw 
later?’ 
Participation in this study is voluntary. It is completely up to you whether or not you 
participate. If you decide not to participate, it will not affect you now or in the 
future. If you wish to withdraw from the study once it has started, you can do so at 
any time without having to give a reason. 
 
4. ‘What does this system involve?’ 
Your involvement in this system will include supervising selected patients taking 
their regular tablets from a blister pack assembled by Ryde Hospital Pharmacy. 
You will need to sign (S) for self-administration on the medication chart once you 
have verified that the correct medications have been taken. You will be required to 
ensure that patients take their tablets from the appropriate blister section and  
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notify the pharmacist or medical team if the patient is having problems  
administering medications from the correct section of the pack. You will be 
required to contact the pharmacist immediately if you notice any medications 
changes on the chart that have not been altered in the current blister pack.  
Medications that can’t be blister packed (e.g. S8/S4D drugs, PRN medications, 
insulin, inhalers, patches, creams, enemas etc.) will be administered to the patient 
in the usual way. Blister packs will be continued when the patient leaves hospital 
via their local chemist. The pharmacist will arrange this. 
 
Involvement in this new system will be required from all nursing staff in order to 
care for patients that will be self-administering their medications, regardless of 
whether you agree to be involved in the study. 
 
5. ‘What does this study involve?’ 
If you agree to participate in this study, you will be asked to sign the Participant 
Consent Form. 
 
You will be asked to fill in a questionnaire (and possibly asked to be interviewed by 
the pharmacist) before implementation regarding your thoughts, opinions and 
concerns about the service. After 2-3 months of service implementation, you will 
be asked to complete the questionnaire again and may be asked to discuss your 
experience further with the pharmacist. The questionnaires and interview will take 
5-10 minutes each to complete.  
 
6. ‘Are there risks to me in taking part in this study?’ 
As your confidentiality will be protected, we do not believe that there are any risks 
to you should you decide to take part.   
 
7. ‘Will I benefit from the study?’ 
No. However, this study may benefit your patients by helping to improve their 
confidence in managing their medications at home and will hopefully reduce 
medication errors at home. 
  
8. ‘Will taking part in this study cost me anything, and will I be paid? 
The study is being funded by the pharmacy department of Ryde Hospital. 
 
Participation in this study will not cost you anything. You will not be paid anything 
extra above your normal wages.  
 
9. ‘How will my confidentiality be protected?’ 
All data collected from you via the questionnaires and/or interviews will be coded 
with a participant number.  Your name or position will not be recorded nor 
published. Hard copies of questionnaires and consent forms will be stored in a 
locked cabinet in pharmacy and electronic data will be stored on a password-
protected PC in pharmacy.  
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10. ‘What happens with the results?’ 
If you give us your permission by signing the consent document, we plan to 
discuss/publish the results of the study as part of a Master of Clinical Pharmacy 
Thesis and potentially present the results at a conference and/or publish results in 
a journal. Results will be presented to the wards during an in-service to inform you 
of the success of the project.  
 
In any publication, information will be provided in such a way that you cannot be 
identified.  
 
11. ‘What should I do if I want to discuss this study further before I decide?’ 
When you have read this information, the researcher Luiza Bozianu will discuss it 
with you and any queries you may have. If you would like to know more at any 
stage, please do not hesitate to contact her via pager 54805. 
 
12. ‘Who should I contact if I have concerns about the conduct of this 
study?’ 
This study has been approved by the Northern Sydney Local Health District 
HREC. Any person with concerns or complaints about the conduct of this study 
should contact the Research Office who is nominated to receive complaints from 
research participants. You should contact them on 02 9926 4590 and quote HREC 
reference number LNR/15/HAWKE/28. 
 
This study adheres to the Guidelines of the ethical review process of The 
University of Queensland and the National Statement on Ethical Conduct in 
Human Research. Whilst you are free to discuss your participation in this study 
with project staff (contactable on (02) 98587513), if you would like to speak to an 
officer of the University not involved in the study, you may contact the Ethics 
Coordinator on (07) 3365 3924. 
 
  
Thank you for taking the time to consider this study. 
If you wish to take part in it, please sign the attached consent form. 
This information sheet is for you to keep. 
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Graythwaite Rehabilitation Centre 
Ryde Hospital 
 
CONSENT FORM 
INTERVENTIONAL STUDY 
Implementation and Evaluation of a Self-Medication System involving Blister 
Packs in the Graythwaite Rehabilitation Centre 
1. I,................................................................................................................of..............
..................................................................................................agree to participate 
as a subject in the study described in the Participant Information Sheet set out 
above. 
 
2. I acknowledge that I have read the Participant Information Sheet, which explains 
why I have been selected, the aims of the study and the nature and the possible 
risks of the investigation, and the statement has been explained to me to my 
satisfaction. 
 
3. Before signing this consent form, I have been given the opportunity of asking any 
questions relating to any possible physical and mental harm I might suffer as a 
result of my participation and I have received satisfactory answers. 
 
4. I understand that I can withdraw from the study at any time without prejudice to my 
relationship to the investigators or Ryde Hospital. 
 
5. I agree that research data gathered from the results of the study may be 
published, provided that I cannot be identified. 
6. I understand that if I have any questions relating to my participation in this 
research, I may contact Luiza Bozianu (Graythwaite Pharmacist) who will be 
happy to answer them. 
 
7. I acknowledge receipt of a copy of this Consent Form and the Participant 
Information Sheet. 
Complaints may be directed to the Research Office on Level 13, Kolling Building, 
Royal North Shore Hospital, St Leonards NSW 2065   
Phone 02 9926 4590 | email NSLHD-research@health.nsw.gov.au  
 
Signature of participant   Please PRINT name   Date 
_______________________________________________________________ 
 
Signature of witness   Please PRINT name   Date 
 
 
Signature of investigator  Please PRINT name   Date 
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Graythwaite Rehabilitation Centre 
Ryde Hospital 
 
INTERVENTIONAL STUDY 
 
Implementation and Evaluation of a Self-Medication System involving 
Blister Packs in the Graythwaite Rehabilitation Centre 
 
REVOCATION OF CONSENT 
 
I hereby wish to WITHDRAW my consent to participate in the study described 
above and understand that such withdrawal WILL NOT jeopardise my relationship 
with the Graythwaite pharmacist / researcher or medical / nursing staff. 
Signature      Date 
Please PRINT Name 
The section for Revocation of Consent should be forwarded to:  
Ms Luiza Bozianu 
Graythwaite Clinical Pharmacist 
Pharmacy Department  
Ryde Hospital 
Denistone NSW 2114 
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Appendix 2: Nurse Pre-Implementation Questionnaire 
 
Nurse Pre-Implementation Questionnaire 
Participant Code: _____________ 
Age: 
Sex (Please circle):   M / F   
Years of practice:  
 
Thoughts and Feelings about Self-Medication System  
Please tick the box that best describes how much you agree or disagree with the following 
statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
Self-medicating in hospital may allow 
patients to be discharged sooner 
□ □ □ □ □ 
Self-medicating may improve patient 
confidence in taking their medicines  
□ □ □ □ □ 
Using a blister pack may reduce the 
number of medication omissions 
□ □ □ □ □ 
Using  a blister pack may reduce 
medication errors (e.g. wrong drug, 
wrong dose) 
□ □ □ □ □ 
Using a blister pack may improve 
patient chances of staying independent 
at home  
□ □ □ □ □ 
Using a blister pack may save time on 
the medication round  
□ □ □ □ □ 
Self-medicating may improve patient 
knowledge of their medications  
□ □ □ □ □ 
Self-medicating will give patients a 
sense of responsibility for their health 
care 
□ □ □ □ □ 
Self-medicating will increase patient 
independence  
□ □ □ □ □ 
Self-medicating in hospital will make 
patients feel trusted   
□ □ □ □ □ 
Self-medicating will improve patient 
relationships with their nurses and 
doctors 
□ □ □ □ □ 
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Self-medicating with a blister pack will 
be convenient for patients 
□ □ □ □ □ 
I believe that the service will benefit 
patients 
□ □ □ □ □ 
Self-medication may allow me to focus 
more time and energy on other clinical 
activities  
□ □ □ □ □ 
 
Concerns about Self-Medication Service 
Please tick the box that best describes how much you agree or disagree with the following 
statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
I am concerned about the accuracy of 
medications in the blister pack 
□ □ □ □ □ 
I would rather administer medications 
from bottles and boxes as usual 
□ □ □ □ □ 
I am concerned that this service will 
increase my workload  
□ □ □ □ □ 
I am concerned that this service will be 
more time consuming  
□ □ □ □ □ 
I am worried that the pack will not be 
updated if patient medications change  
□ □ □ □ □ 
I am worried that patients might take 
medicines from the wrong compartment  
□ □ □ □ □ 
I am worried about using a blister pack 
for medicines that need to be taken with 
special considerations e.g. with food or 
on an empty stomach  
□ □ □ □ □ 
I am worried that patients may not have 
the strength to push the tablets out of 
the pack 
□ □ □ □ □ 
I am worried about not recognizing the 
tablets in the pack to verify the correct 
medicines are given 
□ □ □ □ □ 
I am worried about the stability of the 
tablets in the pack 
□ □ □ □ □ 
I am worried that mandatory  
requirements for medication 
administration outlined in policies and 
procedures do not support blister packs 
□ □ □ □ □ 
I am worried blister packs will cause 
confusion among nursing staff 
□ □ □ □ □ 
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Are there any further benefits you might expect from this self-administration system? Please 
specify: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
Do you have any further concerns about this system not already mentioned above? Please 
specify:  
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
Please write any further comments, thoughts or feelings below: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
______________________________ 
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Appendix 3: Nurse Pre-Implementation Interview 
 
Nurse Pre-implementation Interview: 
Participant Code: _____________ 
 
 What are your overall feelings and opinions about this proposed new system? 
 
 What benefits or problems might you expect from a self-medication system using 
blister packs? (For patients and/or nurses)  
 
 How do you think this new system will affect your current practice? 
 
 How do you think the system will impact on patient independence, confidence and 
ability to manage their medicines at home? 
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Appendix 4: Nurse Post-Implementation Questionnaire 
 
Nurse Post-Implementation Questionnaire 
Name:______________________ 
Participant Code: _____________ 
Thoughts and Feelings about Self-Medication System  
Please tick the box that best describes how much you agree or disagree with each of the 
following statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
Self-medicating in hospital has allowed  
patients to be discharged sooner 
□ □ □ □ □ 
Self-medicating has improved patient 
confidence in taking their medicines  
□ □ □ □ □ 
Using a blister pack has reduced the 
number of medication omissions 
□ □ □ □ □ 
Using  a blister pack has reduced 
medication errors (e.g. wrong drug, 
wrong dose) 
□ □ □ □ □ 
Using a blister pack has improved patient 
chances of staying independent at home  
□ □ □ □ □ 
Using a blister pack has saved time on 
the medication round  
□ □ □ □ □ 
Self-medicating has improved patient 
knowledge of their medications  
□ □ □ □ □ 
Self-medicating has given patients a 
sense of responsibility for their health 
care 
□ □ □ □ □ 
Self-medicating has increased patient 
independence  
□ □ □ □ □ 
Self-medicating in hospital makes 
patients feel trusted   
□ □ □ □ □ 
Self-medicating has improved patient 
relationships with their nurses and 
doctors 
□ □ □ □ □ 
Self-medicating with a blister pack is 
convenient for patients 
□ □ □ □ □ 
I believe that the service has benefited 
patients 
□ □ □ □ □ 
Self-medication has allowed me to focus □ □ □ □ □ 
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more time and energy on other clinical 
activities  
 
Concerns about Self-Medication Service 
Please tick the box that best describes how much you agree or disagree with each of the 
following statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
I am concerned about the accuracy of 
medications in the blister pack 
□ □ □ □ □ 
I would rather administer medications 
from bottles and boxes as usual 
□ □ □ □ □ 
This service has increased my workload  □ □ □ □ □ 
This service is more time consuming  □ □ □ □ □ 
I am concerned that packs are not 
updated when medications change  
□ □ □ □ □ 
I am worried that patients sometimes 
take medicines from the wrong 
compartment  
□ □ □ □ □ 
I am worried about using a blister pack 
for medicines that need to be taken with 
special considerations e.g. with food or 
on an empty stomach  
□ □ □ □ □ 
I am worried that patients may not have 
the strength to push the tablets out of 
the pack 
□ □ □ □ □ 
I am worried about not recognizing the 
tablets in the pack to verify the correct 
medicines are given 
□ □ □ □ □ 
I am worried about the stability of the 
tablets in the pack 
□ □ □ □ □ 
I am worried that mandatory  
requirements for medication 
administration outlined in policies and 
procedures do not support blister packs 
□ □ □ □ □ 
Blister packs cause confusion among 
nursing staff 
□ □ □ □ □ 
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Are there any further benefits you have observed from this self-administration system? Please 
specify: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
From your experience of this new system, do you have any other concerns about it not already 
mentioned above? Please specify:  
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
Please write any further comments, thoughts or feelings below: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
______________________  
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Appendix 5: Patient Pre-Implementation Questionnaire 
 
Patient Pre-Implementation Questionnaire 
Participant Code: _____________ 
We are interested in finding out a bit about you and how you usually manage your medications at 
home. Please read each question and tick the box that represents your answer.  
 
What is your current living arrangement?  
□ Home alone 
□ Home with family/friend/carer 
□ Hostel or retirement village 
□ Other: Please 
specify……………………………………………………………………………………………………………… 
 
How do you manage your medicines at home? (tick all that apply) 
□ I take them myself from their original packets  
□ I take them myself with the help of a medication list 
□ I pack a dosette box for myself  
□ Someone packs  a dosette box for me 
□ I take them myself with someone to assist me 
□ Someone else gives me my medicines without my involvement   
□ Other: Please 
specify……………………………………………………………………………………………………………… 
 
What is your highest level of education? 
□ Primary school 
□ Secondary school 
□ Undergraduate degree 
□ Postgraduate degree 
□ Other: Please 
specify……………………………………………………………………………………………………………… 
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Thoughts and Feelings about Self-Medication in Hospital 
I have self-medicated as a patient in hospital previously  □ Yes     □ No    □ I Don’t 
know  
 
Please tick the box that best describes how much you agree or disagree with each of the 
following statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
Self-medicating in hospital may allow me 
to be discharged sooner 
□ □ □ □ □ 
Self-medicating will improve my 
confidence in taking my medicines  
□ □ □ □ □ 
Using a blister pack may reduce the 
number of medications I miss or forget  
□ □ □ □ □ 
Using  a blister pack may reduce 
medication errors (e.g. wrong drug, 
wrong dose) 
□ □ □ □ □ 
Using a blister pack may improve my 
chances of staying independent at home 
for longer  
□ □ □ □ □ 
Using a blister pack may save my nurse 
time on the medication round  
□ □ □ □ □ 
Self-medicating will improve my 
knowledge of my medications  
□ □ □ □ □ 
Self-medicating will give me a sense of 
responsibility for my health care. 
□ □ □ □ □ 
Self-medicating will increase my 
independence  
□ □ □ □ □ 
Self-medicating in hospital will make me 
feel trusted  
□ □ □ □ □ 
Self-medicating may improve my 
relationship with my nurses and doctors 
□ □ □ □ □ 
Self-medicating with a blister pack will 
be convenient  
□ □ □ □ □ 
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Concerns about Self-Medication Service 
Please tick the box that best describes how much you agree or disagree with each of the 
following statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
I am concerned about the accuracy of 
medications in the blister pack 
□ □ □ □ □ 
I would rather have a nurse give my 
medications  
□ □ □ □ □ 
I am concerned that this service will 
increase the workload of the nurses 
□ □ □ □ □ 
I am concerned that this service will be 
time consuming for my nurse 
□ □ □ □ □ 
I am worried that my pack will not be 
updated if my medications change  
□ □ □ □ □ 
I am worried that I might take medicines 
from the wrong compartment  
□ □ □ □ □ 
I am worried about using a blister pack 
for medicines that need to be taken with 
special instructions, for example, with 
food or on an empty stomach   
□ □ □ □ □ 
I am worried that I won’t have the 
strength to push the tablets out of the 
pack 
□ □ □ □ □ 
I am worried about not recognizing the 
tablets in the pack 
□ □ □ □ □ 
I am worried that I will forget to ask the 
nurse for my medicines when they are 
due  
□ □ □ □ □ 
I am worried about the tablets degrading 
in the pack 
□ □ □ □ □ 
Nurses and doctors might not approve of 
me self-administering my medications in 
hospital 
□ □ □ □ □ 
I am worried about paying for ongoing 
blister packs when I go home  
□ □ □ □ □ 
I am worried that the blister pack will be 
confusing 
□ □ □ □ □ 
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Are there any other benefits you might expect to have from this system? Please specify: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
Do you have any further concerns about this system not already mentioned above? Please 
specify:  
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
Please write any further comments, thoughts or feelings below: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
______________________________ 
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Appendix 6: Patient Post-Implementation Questionnaire 
 
Patient Post-Implementation Questionnaire 
Participant Code: _____________ 
Thoughts and Feelings about Self-Medication System  
Please tick the box that best describes how much you agree or disagree with each of the 
following statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
Self-medicating in hospital has allowed 
me to be discharged sooner 
□ □ □ □ □ 
Self-medicating has improved my 
confidence in taking my medicines  
□ □ □ □ □ 
Using a blister pack has reduced the 
number of medications I miss or forget  
□ □ □ □ □ 
Using  a blister pack has reduced 
medication errors (e.g. wrong drug, 
wrong dose) 
□ □ □ □ □ 
Using a blister pack has improved my 
chances of staying independent at home 
for longer  
□ □ □ □ □ 
Using a blister pack has saved my nurse 
time on the medication round  
□ □ □ □ □ 
Self-medicating has improved my 
knowledge of my medications  
□ □ □ □ □ 
Self-medicating has given me a sense of 
responsibility for my health care. 
□ □ □ □ □ 
Self-medicating has increased my 
independence  
□ □ □ □ □ 
Self-medicating in hospital has made me 
feel trusted  
□ □ □ □ □ 
Self-medicating has improved my 
relationship with my nurses and doctors 
□ □ □ □ □ 
Self-medicating with a blister pack has 
been convenient  
□ □ □ □ □ 
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Concerns about Self-Medication Service 
Please tick the box that best describes how much you agree or disagree with each of the 
following statements: 
Questions Strongly 
disagree 
Disagree  Neither 
agree 
nor 
disagree 
Agree Strongly 
agree 
I am concerned about the accuracy of 
medications in the blister pack 
□ □ □ □ □ 
I would have preferred to have a nurse 
give my medications  
□ □ □ □ □ 
I feel that this service has increased the 
workload of the nurses 
□ □ □ □ □ 
I feel that this service has been time 
consuming for my nurse 
□ □ □ □ □ 
I was worried that my pack would not be 
updated in time if my medications 
changed 
□ □ □ □ □ 
I am worried that I might take medicines 
from the wrong compartment at home  
□ □ □ □ □ 
I am worried about using a blister pack 
for medicines that need to be taken with 
special instructions, for example, with 
food or on an empty stomach  
□ □ □ □ □ 
I am worried that I won’t have the 
strength to push the tablets out of the 
pack 
□ □ □ □ □ 
I am worried about not recognizing the 
tablets in the pack 
□ □ □ □ □ 
I was worried that I would forget to ask 
the nurse for my medicines when they 
were due  
□ □ □ □ □ 
I am worried about the tablets degrading 
in the pack 
□ □ □ □ □ 
I felt that nurses and doctors did not 
approve of me self-administering my 
medications in hospital 
□ □ □ □ □ 
I am worried about paying for ongoing 
blister packs when I go home  
□ □ □ □ □ 
Using the blister pack is confusing □ □ □ □ □ 
 
If you came into hospital again, would you like to administer your own medicines again? 
 Yes 
 No 
 I don’t know 
86 
 
 
Are there any other benefits you have gained from self-administering your medicines? Please 
specify: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
From your experience of self-medicating in hospital, do you have any other concerns about the 
system not already mentioned above? Please specify 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________________ 
 
Please write any further comments, thoughts or feelings below: 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
______________________________ 
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Appendix 7: Ethics Approval Letters
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Appendix 8: Record Sheet for Medication-Related Incidents 
 
Date Incident Type How overcome  How could be 
avoided  
in future  
Comments 
 
 e.g. 
Wrong drug 
Wrong strength 
Omitted drug 
Incorrect number of 
tablets 
 
   
22/6/15  Wrong strength - 
Mestinon 60mg tablets 
packed in blister pack 
instead of 10mg tablets 
– slipped through 
pharmacist final check. 
Nurse and patient found 
error as patient did not 
recognise colour of 
tablets and description 
of tablet on back did not 
match what was packed 
(colour) 
 
RN brought pack 
down to 
pharmacy and 
repacked with 
correct strength 
Ensure packing 
pharmacy 
assistant and 
checking 
pharmacist looks 
at tablet 
descriptions on 
back of pack and 
verifies with drugs 
dispensed/packed. 
Tablets were 
same size and 
shape, however 
10mg tablets 
were white and 
60mg tablets 
were peach 
colour. 
29/6/15 Omitted drug – Coloxyl 
and Senna omitted from 
dinner medication 
pocket 
 
Discovered by 
principle 
investigator when 
delivering pack to 
ward  
Checking 
pharmacist 
notified of missed 
error. Pharmacy 
assistant notified 
of error. Both 
pharmacist and 
pharmacy 
assistant advised 
to check against 
medication chart 
and list at back of 
pack  
Dinner pocket 
empty when 
should have had 2 
x Coloxyl and 
Senna tablets 
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Appendix 9: Reflective Diary  
 
Questions/issues come across during nurse education pre-implementation and their 
resolutions: 
1. 26/2/15 What happens when a patient goes on gate leave? Do we give them their blister 
pack to use unsupervised? 
Pharmacy will pack a separate blister pack for gate leave containing only the medications needed 
during the gate leave period. This minimises risk of error and overdose. Other medications not 
suitable for packing maybe need to be provided separately e.g. PRN medications.  
2. 26/2/15 If a packed medication was to be with-held by the medical team, or refused by 
the patient, how will we identify it in the pack? 
The reverse side of the pack will contain a list of the medications in each pocket along with a short 
description of the tablet’s appearance. You can verify tablet identity based on the appearance 
descriptor and pocket location.  
3. 4/3/15 Will nurses have to order ongoing supply of blister packs from the pharmacy or 
will they be replenished and delivered on a designated day automatically? 
Blister packs may be initiated for a patient on any weekday. Initial blister packs will only be packed 
up until Sunday evening doses (i.e. they may be partial packs if not started on a Monday). 
 Ongoing blister packs will be delivered to the ward on Friday afternoons and are to be started on 
Monday mornings.  
4. 9/3/15 – What if the patient pops out the wrong pocket? What do we do with the meds 
they have already popped out? 
Place the meds popped out in a bottle and label with: 
 Patient name 
 MRN 
 Drug information (drug names and strengths) 
 What pocket it came from e.g. “Thursday Dinner”  
 
 
5. 9/3/15 – Are we going to assess the patients can pop out meds before they start using a 
blister pack? They may not have the strength or dexterity to do this. 
 
We can assess the patient’s ability to access meds from the pack by using a dummy pack with 
lollies in it. Call pharmacist to arrange and assess patient ability before packs are made. 
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Issues with Patient Recruitment  
 
10/4/15 - One patient was scared / apprehensive about signing consent form to be part of study 
as she felt she may be agreeing to something unusual or serious. She wished to discuss it with her 
husband first before signing. (Even though she thought self-administration and use of a blister 
pack was a great idea). Delay in recruitment as husband didn’t come to visit for over 4 days. Once 
husband consulted, he decided he didn’t agree as he was happy to look after her meds at home 
and wished to maintain this carer role.  
 
Multidisciplinary team slow to warm to idea of patient nomination at weekly case conference. 
Possibly felt this would be extra work for them or hadn’t thought about which patients may be 
appropriate prior to meeting. Possibly inclusion and exclusion criteria too narrow, as many team 
members proposed that certain patients did not fit the criteria for various reasons e.g. unsure 
about cognitive function, has a carer or family member to help with meds etc. Ongoing issue with 
patient nomination from multidisciplinary meeting.  
 
Patients being nominated too close to discharge date, hence not enough time to determine if 
they have any issues using the blister pack independently – therefore not recruited into study. 
 
 
Number of patients deemed appropriate by multidisciplinary team but not recruited (by 
reason): 
Reason why not eligible or refused Number of Patients 
Not interested in participating in study (various 
reasons) 
8 
Discharge date in 3 days – not enough time in 
study 
5 
<5 meds appropriate for packing 3 
Already using a blister pack at home 2 
Vision impaired 2 
Will self-discharge against medical advice 1 
RACF now discharge destination 1 
Refused to consent 1 
Cost of blister packs too expensive 1 
Cannot physically pop out tablets due to injury 1 
Family disagreed   1 
 
 
 
ISSUES WITH PACKING 
 
13/4/15 - One patient had Domperidone 10mg TDS packed, however this medication should be 
taken half an hour before meals for best effect. It was packed in the same pockets as medication 
that should be taken with food i.e. Slow K.  
Resolution: Blister pack repacked without Domperidone inside, to be given by nurses separately 
half an hour before meals.  
 
3/6/15 – Patient prescribed Gabapentin three times a day, which was packed in blister pack 
according to times listed on medication chart. Patient complained that times were not 
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appropriate in blister pack as it was different to her pain management regime at home. 
Administration times discussed with doctor and patient. Webster pack changed to reflect the 
administration times that kept her pain controlled.  
 
22/6/15 - Mestinon 60mg tablets were packed in a blister pack instead of 10mg tablets. This error 
slipped through the final check and was sent to the ward. Nurse and patient discovered error as 
the patient did not recognise the different colour of tablets, and description of tablet on back did 
not match what was packed (colour). Nurse brought pack down to pharmacy to be repacked with 
correct strength.  Tablets were the same size and shape, however 10mg tablets were white and 
60mg tablets were peach colour. 
How could be avoided: Ensure packing pharmacy assistant and checking pharmacist looks at 
tablet descriptions on back of pack and verifies with drugs dispensed/packed. 
29/6/15 - Omitted drug – Coloxyl and Senna omitted from dinner medication pocket. Discovered 
by principle investigator when delivering pack to ward. Checking pharmacist notified of missed 
error. Pharmacy assistant notified of error. Both pharmacist and pharmacy assistant advised to 
check against medication chart and list at back of pack. Dinner pocket empty when should have 
had 2 x Coloxyl and Senna tablets. 
 
 
  
94 
 
Appendix 10: Patient Post-Implementation Interview 
 
Patient POST-implementation Interview 
Participant Code: _____________ 
 
 Tell me about your experiences of the new self-administration system. 
 
 Has this system benefited you? How? 
 
 Do you feel that the system saves time for your nurse? Why / Why not?  
 
 Do you feel that using a blister pack has affected your independence, confidence or 
ability to manage your medicines at home? How? 
 
 Have you experienced any issues or problems with the self-medication system?  
 
 What current concerns do you have about the self-medication system?  
 
 Do you have any suggestions of ways in which we can improve the current system? 
 
 What are your overall feelings and opinions about this new system? 
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Appendix 11: Nurse Post-Implementation Interview 
 
Nurse POST-implementation Interview 
Participant Code: _____________ 
 
 Tell me about your experiences of the new self-administration system. 
 
 What benefits have you observed from your patients and/or other staff members? 
 
 Tell me about any issues you have observed or encountered with the system. 
 
 Have these issues impacted on patient care? Please elaborate. 
 
 Do you feel that the system saves time or is time consuming? Please elaborate. 
 
 How do you feel the system impacts on patient independence, confidence and 
ability to manage their medicines at home? 
 
 What current concerns do you have about the self-medication system?  
 
 Do you have any suggestions of ways in which we can improve the current system? 
 
 Have your feelings, opinions or concerns about this system changed from before 
implementation to now? How? 
 
 What are your overall feelings and opinions about this new system? 
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Appendix 12: Demographic Data Collection Tool 
 
STUDY: Implementation and Evaluation of a Self-Medication 
System Involving Blister Packs in the Graythwaite Rehabilitation 
Centre 
 
PATIENT DEMOGRAPHIC DATA COLLECTION SHEET 
 
 
Participant code: _______ 
 
 
Age  
Sex  
Education  
 
Living arrangement  
 
Medical history  
 
 
 
 
 
Medication history  
 
 
 
 
 
 
 
 
 
Number of days in the 
study 
 
Length of stay in the 
rehabilitation ward 
 
Length of overall 
hospital stay 
 
 
